Author: acn

业绩摘要：- 收入增长41%至62.30亿港元，创历史新高- 税后利润跃升287%至13.45亿港元- 总资产上升18%至1,535亿港元- 金融产品业务规模上升18%至474亿港元- ROE显著提升6.4个百分点至8.7%- 建议派发末期股息每股2港仙，全年派息7港仙，派息比率50%，每股股息增长119%业务亮点：- 投行业务创历史最佳表现，收入大幅增长133%- 港股IPO保荐项目7个，配售项目34个，配售按数量市场排名第一- 债券发行项目294个，发行规模增长34%- OTC产品交易量爆发式增长，成为佣金收入主力来源之一- 港交所场内衍生品累计成交中资券商排名第一- 资产管理业务规模增长49%，收入大幅增长1.2倍- 中资离岸ESG债券主承销金额中资券商排名第一- 连续10年获穆迪"Baa2"、标普"BBB+"长期发行人评级，展望"稳定"- MSCI ESG 获提升至最高AAA评级， 连续第三年营运层面碳中和香港, 2026年3月25日 - (亚太商讯 via SeaPRwire.com) - 国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"、"集团"或"公司"，股份代号：1788.HK）秉持稳健务实的经营理念，坚守风险底线，聚焦核心主业，推动各业务实现全面高质量增长，经营成果丰硕。年内，集团收入创历史新高，同比大幅上升41%至62.30亿港元，普通股股东应占溢利同比大幅跃升287%至13.45亿港元，盈利规模实现跨越式提升。董事会建议宣派截至2025年12月31日年度之末期股息每股0.02港元，连同已派发的中期股息每股0.05港元，全年股息合共每股0.07港元，派息比率50%，每股股息增长119%。厚积薄发，财富管理2.0拉开帷幕2025年，集团全面推进财富管理2.0战略落地，坚持"客户需求为核心、定制化服务为特色、数字化能力为支撑"的发展方向，完成"平台+产品"综合性升级。年内，OTC产品交易增长迅猛，成为佣金收入主力来源之一，其中结构性票据、OTC期权佣金均同比跃升超过100%，产品交易量、客户参与人数较2024年分别增长超50%，成为集团财富管理业务高质量发展的核心支柱。同时，集团深化科技金融与普惠金融布局，完成交易平台数智化升级，"君弘全球通"活跃用户大幅增长，有效带动客户托管资产规模提升。2025年，集团资产管理业务实现规模、收入双增长，资产管理规模同比增长49%，收益跃升1.2倍。投资级债券基金Class I年化回报率达8.96%，位列中资同业前茅；美元货币基金Class A2年化回报率约4.38%，稳居同类产品第一梯队。企业融资创佳绩，规模效益创新高依托与母公司国泰海通证券的协同优势，2025年，集团股权融资业务继续聚焦新科技、机器人、人工智能等前沿赛道，创历史最好表现，全年共完成七单IPO保荐项目，数量居中资投行前列，集资总额超过160亿港元，递交上市申请共25个项目（不含保密递交的申请）。其中，本集团独家保荐的上海剑桥科技（6166.HK）创下A股与港股通信设备行业史上最大规模IPO记录；卧安机器人（6600.HK）为智慧家庭机器人第一股；集团联席保荐的禾赛科技（2525.HK）为2022年以来募资规模最大的中概股回归项目。此外，年内，集团完成34个二级市场配售项目，按项目数量计排名市场第一。2025年，集团共参与294笔境外债券的发行项目，发行总规模约5,221亿港元，同比增长34%。根据DMI债券平台数据显示，集团离岸债一级承销规模在中资券商中排名第三，中资离岸债主承销规模位列中资券商第二。集团服务客户涵盖大型国有企业、金融机构、地方政府等各类发债主体，业务实力稳居行业领先地位。机构业务稳定发展，产品服务领跑市场集团持续为机构投资者提供跨境、跨资产、跨市场一站式服务，依托沪港通、深港通等互联互通机遇，深化与母公司协同，整合境内外资源优势，提升产品设计与交易能力。截至2025年年底，代客持有金融产品规模同比增长17.7%至474亿港元，净收益平稳提升。在港股衍生品领域，集团场内衍生品交易量同比显著增长，稳居中资券商领先地位。深耕绿色金融，推进低碳运营本集团坚守"金融报国，金融为民，金融向善"信念，将ESG理念融入日常业务营运及管理中。在绿色金融服务方面，集团持续深耕ESG债券市场，年内完成86笔ESG债券发行，融资规模约达2,044亿港元，同比增加25%，于DMI中资离岸ESG债券主承销金额排名中位列中资券商第一名，彰显了在绿色金融领域的领先地位。低碳运营发展方面，公司在坚持践行节能减排的基础上，通过认购核证碳标准林业项目碳汇资产成功抵销2024年度范围1及范围2温室气体排放，连续第三年实现营运层面碳中和，展现了本公司在应对气候变化方面的坚定承诺和卓越表现。本公司MSCI ESG、万得ESG和商道融绿ESG的评级均领先同业，其中MSCI ESG评级达最高AAA级，标普全球ESG评分领先全球81%同业，彰显可持续发展核心竞争力。展望2026年，国泰君安国际将坚持稳中求进总基调，主动应对市场变化，聚焦核心业务提质增效，深化客户中心理念，构建覆盖机构、企业及个人客户的全周期综合金融服务体系，持续提供精准、多元、高效的一站式金融解决方案，推动各项业务高品质发展再上新台阶。完整版公告请参阅：https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032500354_c.pdf声明本文稿不构成购买或认购任何证券或金融工具或提供任何投资建议的邀请或要约，幷且其任何部分不构成或依赖与任何合同、承诺或与此相关的投资决策，本文稿亦不构成有关公司之证券或金融工具的建议。本文稿包含有关集团财务状况、经营业绩的若干前瞻性陈述，及集团管理层的若干计划及目标。这些前瞻性陈述涉及已知和未知的风险、不确定性和其他因素，可能导致实际业绩或业绩与前瞻性陈述所表达或暗示的任何未来业绩或业绩截然不同。这些前瞻性陈述是基于集团现在和将来的策略以及集团将来经营的政治和经济环境的假设。不应将这些前瞻性陈述放在这些前瞻性陈述之上，反映集团管理层截至本次发布的观点。不能保证未来的结果或事件与任何这样的前瞻性陈述一致。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK）, 是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高品质、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的资讯请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月25日 - (亚太商讯 via SeaPRwire.com) - 全民养生潮爆发。不只是中老年"银发群体"，就连Z世代都不"浪"了，开始学习中医知识、吃食补药膳、打太极拳......在某视频平台，《八段锦》的播放量高达7880万。在某社交平台，"健康养生"话题的浏览量累计超过百亿次。政策持续支持，近期又加了把"火"。十五五规划纲要明确：全面实施AI+。加快建设健康中国，推进中医传承创新。需求和政策的双重驱动下，中医医疗服务行业的确定性愈加凸显。据弗若斯特沙利文测算，到2029年，市场规模将达到1.62万亿元，未来几年的CAGR约9.9%。[1]同时，一家万亿风口上的"龙头"--同仁堂医养，正备受青睐。一方面，它积极拥抱AI，以优质普惠的中医医养服务+成熟供应链，收获了全国超过76万会员用户的信任。另一方面，作为"AI+中医医疗服务"龙头，它是稀缺的"压舱石"资产，不仅填补了港股空白，也让全球投资者能够分享中国人口转型和民族医药复兴的红利。机构投资者嗅觉敏锐，已抢先布局。据悉，航空港科技资本、Aurora SF，已经与同仁堂医养签订了基石投资协议。值得注意的是，他们已承诺，上市后7个月内不会卖出。这一禁售期限，比港交所的规定（最低6个月）更长。显然，这是看好同仁堂医养的中长期价值。而在当下的港股市场，信心比黄金更重要。1、全产业链协同，夯出百年护城河十年前养生，"西式产品"风靡全球。如今，望闻问切、药膳膏方、针灸推拿等"中式医养方案"，正越来越火。甚至连老外也争相加入，直呼"上头，舒服"。风向的转变，源于中医医养的独特优势：治未病，副作用较小，强调人体内部系统的平衡与和谐，更注重养生保健和长期健康管理。这，正好适配当前的养生需求。老龄化趋势叠加快节奏生活，我国慢性病患病率不断上升。据国家卫健委统计，有75.8%的老年人至少被1种慢性病困扰。[2]从高层到行业，已经形成共识：中医医养服务，有助于提升国民健康质量。但，问题出在了供给端。经验丰富的中医医师极度稀缺，且大多执业于三甲医院。即便患者抢到了专家号，诊疗结束即服务终止，后续很难再互动，更遑论持续的健康管理。该如何破局？同仁堂医养敢于啃"硬骨头"，给出了解题思路：全产业链协同。品牌端，同仁堂拥有350余年历史，家喻户晓，自带"信任基石"。同时，它始终锚定医疗服务的本质，潜心练功，锻造出了严肃专业、高质量的医疗服务能力。截至去年9月末，平台拥有2745名中医执业医师。其中，820名是主任医师或副主任医师，有30名执业医师拥有国家级荣誉称号。在此基础上，同仁堂医养进一步打通服务堵点，线上线下融合协同，已建立起全面、强大的分级诊疗网络。在线上，数智化诊疗平台突破时空限制，"老中医"7×24小时极速响应，使优质的中医医养服务更加普惠。在线下，基层连锁机构覆盖社区场景，提供及时、贴心、温暖的医疗需求，例如开展社区义诊，为老人提供家庭医生服务等。连锁化的中医院，有传承，又有创新。它拥有先进的医学检查设备和领先的优势专科能力，聚焦精细化医学检查和系统性诊疗服务，与互联网医院、基层机构，互为补充，大幅优化了资源配置。但，一家极致的公司，还不止于此。同仁堂医养希望"把简单留给用户"，它背靠同仁堂集团，自带中医药和供应链基因，"炮制虽繁必不敢省人工，品味虽贵必不敢减物力"。当诊疗完成后，它能直接提供优质可靠的药品、药膳、慢病调理膏方。至此，中医医养-医药供应链，形成了闭环服务生态。患者无需折腾，就能享受到优质、高效的医疗健康服务。用户纷纷投出"信任票"。2025年前9个月，同仁堂医养的推广费占总营收比重仅0.1%。但同时期，总就诊人次达到250万人次，同比增长21.6%。会员人数方面，2022年-2024年CAGR达到30.2%，2025年前九个月增长至76.66万。据弗若斯特沙利文调研数据，按2024年总门诊人次及住院人次计，同仁堂医养是中国非公立中医院医疗服务行业中最大的中医院集团，妥妥的行业龙头。这，正是市场给予"新质供给"的掌声和回报。2、高质量增长，强劲稳健的基本面当前，同仁堂医养正处于港股招股阶段，已引入2家基石投资者，散户投资者也正积极踊跃申购。投资的底层逻辑，是强劲稳健的基本面。IPO招股书显示，2022年-2024年，同仁堂医养营业收入分别为9.11亿元、11.53亿元、11.75亿元，持续稳健增长。2025年前9个月，营收8.58亿元，保持增长势头。同时，其营收结构显著优化，销售健康产品及其他产品的占比达到13.6%，验证了全产业链协同的逻辑。从地区来看，北京、浙江以外地区的营收规模增长了约17%，营收占比提升了2个百分点，意味着，业务扩张已见成效。利润方面，同仁堂医养于2023年扭亏后，一直保持着盈利状态。2025年前9个月，得益于标准化运营+数智化转型，其经营质效进一步提升，费用率优化至13.6%，毛利率18.2%。以长期视角看，这样的高质量增长，才刚刚开始。招股书显示，2024年，同仁堂医养的市场份额为1.7%，整合空间巨大。未来，中医医疗服务赛道将进入高景气周期，规模万亿级。作为行业龙头，同仁堂医养已经构筑起坚实的"护城河优势"，且用户信任、高粘性。另外，它拥有健康的现金流，此次IPO后，"资金弹药"将更加充裕，能够支撑业务扩张。可以预见，强者恒强，它有望吃下更多的"蛋糕红利"。3、乘AI东风，开辟医养"新航线"AI重塑医疗健康，数千年的中医智慧正与新技术碰撞融合，焕发新生。中国工程院院士张伯礼认为，AI赋能，可以让中医更快地进步，飞得更高、飞得更远。这是历史性的机遇，也是每一家公司的必答题。同仁堂集团精准洞悉趋势，积极拥抱AI浪潮。去年，其"牵手"小米公司，共同推出了AI智能体"同仁堂养生馆"，它是一个AI中医药健康管家，能提供"健康问询-分析-个性化建议"全流程服务。研发端，在北京市经济和信息化局的支持下，其已落地AI新药开发平台建设项目，将构建十万级方剂数据库，驱动"经验主义"进化至"数据主义"。同时，生产制造端也在"智变"。据悉，同仁堂集团旗下的"中医药全生命周期数智管控智能工厂"，已构建起13个AI应用场景，关键生产环节已全面完成智能化改造，实现了"全链智能"。作为大健康生态的"终端"，同仁堂医养是"数智化排头兵"，也正加速推进中医医疗服务的数智化转型。本次募资中，将有约5%的资金用于智慧医疗、数字化和智慧化改造。这将为其带来更多的想象力。例如，AI将"解放"医生，重构生产力，将使优质中医医养服务更加普惠、效率更高。当越来越多用户涌入，不只会带来业绩的飞跃，还会产生更多数据反馈，驱动上游中医药产品的创新研发。另外，AI还将助力管理服务业务，加速"同仁堂标准"的输出。未来，同仁堂医养可能不只是一家To C的医疗服务公司，还有望进阶成为一家To H（医疗机构）的技术输出公司。乘AI东风，一家百年老字号，正开辟"新航线"。同仁堂医养，战乱世界的"压舱石"，已经站上了价值迁跃的新起点。参考资料：[1]同仁堂医养IPO招股书[2]慢性病成老年健康头号杀手，如何做好慢病管理？-中国新闻网转载自懂财帝 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SAN DIEGO, Mar 25, 2026 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI) was named the winner of two awards during Aviation Week's 21st annual Program Excellence Awards last week. GA-ASI's United Kingdom (UK) Protector Program was given the Special Projects Award, while its Japan COCO (Company-Owned, Company-Operated) Program won in the category of OEM System Sustainment."We're excited that these two important MQ-9B international programs have been recognized by Aviation Week," said GA-ASI CEO Linden Blue. "We're fortunate to have an incredible team of employees whose dedication and commitment to our customers is truly remarkable."MQ-9B is GA-ASI's most advanced Remotely Piloted Aircraft (RPA) system and includes the SkyGuardian® and SeaGuardian® models, as well as the UK's Protector RG Mk1.In 2025, GA-ASI achieved the first-ever Military Type Certificate (MTC) for the Royal Air Force's (RAF) Protector RG Mk1, passing a rigorous airworthiness assessment and verifying its safe operation without geographic restrictions. The global impact of the UK Protector MTC was recognized because it's a singular achievement that enables routine UAS operations in civil airspace from domestic RAF bases, drastically expanding its operational flexibility and reducing reliance on segregated ranges or overseas deployments. But more importantly, it serves as a proof of concept for future unmanned systems seeking full integration into regulated airspace and sets a precedent for allied and NATO forces worldwide.In Japan, the MQ-9B SeaGuardian COCO Program has proven so successful that the aircraft that had been leased to Japan have now been converted to sales, with additional MQ-9Bs now on order. SeaGuardian has been used by Japan to deliver real-time situational awareness anywhere in the maritime domain - day or night. It is also the first RPA in its class to enable real-time search and patrol above and below the ocean's surface.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, MQ-9B SkyGuardian®/SeaGuardian®, XQ-67A, and YFQ-42A. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.GA-ASI Media RelationsGeneral Atomics Aeronautical Systems, Inc.ASI-MediaRelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

圣地亚哥, 2026年3月25日 - (亚太商讯 via SeaPRwire.com) - 通用原子航空系统公司（GA-ASI）在上周举行的《航空周刊》第21届年度“项目卓越奖”评选中斩获两项大奖。GA-ASI的英国“保护者”项目荣获“特别项目奖”，而其日本COCO（公司自有、公司运营）项目则在“原始设备制造商系统维护”类别中摘得桂冠。“我们很高兴这两个重要的MQ-9B国际项目获得了《航空周刊》的认可，”通用航空系统公司（GA-ASI）首席执行官林登·布鲁表示。“我们很幸运拥有一支卓越的员工团队，他们对客户的奉献精神和承诺确实令人赞叹。”MQ-9B是GA-ASI最先进的遥控飞行器（RPA）系统，包括SkyGuardian®和SeaGuardian®型号，以及英国的Protector RG Mk1。2025年，通用航空系统公司（GA-ASI）为英国皇家空军（RAF）的“保护者”RG Mk1无人机获得了首张军用型号证书（MTC），该机型通过了严格的适航性评估，并证实了其在无地理限制条件下的安全运行能力。英国“保护者”MTC的全球影响力得到了广泛认可，因为这是一项独一无二的成就，它使无人机能够从英国皇家空军国内基地出发，在民用空域进行常规飞行，极大地扩展了其作战灵活性，并减少了对隔离试飞场或海外部署的依赖。但更重要的是，它为未来寻求全面融入受监管空域的无人系统提供了概念验证，并为全球盟军和北约部队树立了先例。在日本，MQ-9B“海卫士”COCO计划取得了巨大成功，此前租赁给日本的飞机现已转为销售，且已追加订购了更多MQ-9B。日本利用“海卫士”在昼夜不分的海域范围内提供实时态势感知能力。它也是同类无人机中首款能够实现海面及水下实时搜索与巡逻的机型。关于GA-ASI通用原子航空系统公司（General Atomics Aeronautical Systems, Inc.）是全球领先的无人机系统（UAS）制造商。“捕食者®”（Predator®）系列无人机系统已服役超过30年，累计飞行时长逾900万小时，产品包括MQ-9A“死神®”（Reaper®）、MQ-1C“灰鹰®”（Gray Eagle®）、MQ-20“复仇者®”（Avenger®）、MQ-9B“天卫®”（SkyGuardian®）/“海卫®”（SeaGuardian®）、XQ-67A以及YFQ-42A。公司致力于提供长航时、多任务解决方案，以实现持续态势感知和快速打击能力。如需了解更多信息，请访问 www.ga-asi.com 。Avenger、EagleEye、Gray Eagle、Lynx、Predator、Reaper、SeaGuardian 和 SkyGuardian 是通用原子航空系统公司（General Atomics Aeronautical Systems, Inc.）在美国和/或其他国家注册的商标。GA-ASI 媒体关系部通用原子航空系统公司ASI-MediaRelations@ga-asi.com (858) 524-8101来源：通用原子航空系统公司 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Reno, Nevada--(ACN Newswire via SeaPRwire.com - March 24, 2026) - Scandium Mining Corp. (TSXV: SCY) (OTC PINK: SCYYF) ("Scandium International" or the "Company"), a leader in the advancement of critical mineral resources, is pleased to announce the release of its updated investor presentation, now available to investors and stakeholders. The new presentation can be accessed here: Investor PresentationThe new investor presentation provides updated information on the Nyngan project in New South Wales, Australia, which is now fully shovel-ready. This project is one of only two primary scandium deposits at this advanced stage in the western world, positioning the company at the forefront of the emerging scandium market.Scandium is an essential element in high-performance applications, including aerospace, defense, and clean power generation. Its unique properties-such as exceptional strength-to-weight ratio and improved corrosion resistance when alloyed with aluminum-make it indispensable for the next generation of lightweight, durable materials. As demand grows for advanced technologies and sustainable solutions, scandium's role is increasingly being recognized by innovative manufacturers and governments alike."We're excited to share this comprehensive update on our progress," said Peter Evensen, CEO of Scandium International. "With our mining license now valid over the entire resource, the project is shovel-ready and we are uniquely positioned to supply scandium at scale to industries that are shaping the future."To view the latest presentation and learn more about Scandium Mining's plans, visit: Scandium International Mining CorporationAbout Scandium MiningScandium Mining is dedicated to unlocking the potential of scandium for high-impact industries worldwide. With its shovel-ready primary scandium deposit, the company is committed to responsible development and long-term value creation.For inquiries to Scandium International Mining Corp, please contact: Peter Evensen, President and CEOTel: (775) 355-9500Harry de Jonge (Controller)Tel: (702) 703-0178Email: info@scandiummining.comCautionary Note Regarding Forward-Looking InformationThis news release includes certain information that may be deemed "forward-looking information". Forward-looking information can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "believe", "continue", "plans" or similar terminology, or negative connotations thereof. All information in this release, other than information of historical facts, general future plans and objectives for the Company and the Nyngan Scandium Project, are forward-looking information that involve various risks and uncertainties. Although the Company believes that the expectations expressed in such forward-looking information are based on reasonable assumptions, such expectations are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking information.For more information on the Company and the key assumptions, risks and challenges with respect to the forward-looking information discussed herein, and about our business in general, investors should review the Company's most recently filed annual information form, and other continuous disclosure filings which are available at www.scandiummining.com Readers are cautioned not to place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/289611 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 国际指数评级机构明晟 MSCI日前公布了年度 ESG（环境、社会及企业管治） 评级报告，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"或"公司"，股份代号：1788.HK））评级从"A"级跃升至最高"AAA"级。公司在负责任投资、可持续融资业务、人力资本发展、数据安全及企业行为等领域表现尤为突出，处于全球同业领先水平。这一重要突破标志着公司在可持续发展领域的持续努力与卓越表现获得国际权威机构的高度认可。根据MSCI ESG评级的最新评估，国泰君安国际在多个关键议题上表现优异，成为本次评级上调的主要驱动因素：在负责任投资方面，得益于可持续发展指标的优化调整，公司得分显著提升。公司始终致力于可持续发展，将负责任的投资理念全面融入投资组合管理，在投资流程中系统性地纳入ESG因素，以此在传统财务分析基础上，进一步增强对潜在投资的ESG表现评估，从而推动被投资方的绿色转型。在可持续融资业务方面，国泰君安国际在投资银行业务中积极开展可持续发展尽职调查，并通过为企业客户承销及发行绿色债券，持续推动绿色金融发展，降低与业务相关的环境风险，展现了其在绿色投融资领域的责任担当与专业能力。在人力资本发展方面，由于绩效评估方法论的改进以及公司实践的持续完善，得分亦实现增长。公司秉持"人才是第一资源"的经营理念，并奉行"以人为本、协同协作"的原则，视员工为本集团最有价值的资产。通过提升薪酬待遇、提供员工福利、创造成长机会，持续加强人才招募和留任策略，进一步巩固公司作为优选雇主的地位，推动长期可持续发展。在数据安全领域，MSCI报告指出，国泰君安国际主要运营于香港这一隐私保护法规较为严格的地区，公司在数据安全实践方面保持行业领先，通过制定覆盖全集团的隐私政策，并引入外部独立IT安全审计，公司有效构筑了网络安全风险防线。国泰君安国际此次MSCI ESG评级跃升至AAA级，充分体现了公司在环境、社会及管治方面的长期投入与系统化建设成果。作为国泰海通集团的重要国际业务平台，公司将继续秉持可持续发展理念，深化ESG治理实践，积极履行社会责任，为股东、客户及社会创造长期可持续价值。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK）,是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高品质、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的资讯请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 24, 2026 - (ACN Newswire via SeaPRwire.com) - Baguio Green Group Limited (‘‘Baguio’’ or the ‘‘Group’’, Stock Code: 01397.HK) is pleased to announce its annual results for the year ended 31 December 2025 (the “Year”).During the Year, the Group’s revenue amounted to approximately HK$2,424.6 million, representing a decrease of approximately 6.9% as compared to the same period last year. Profit for the Year amounted to approximately HK$97.1 million, representing an increase of approximately 72.0% as compared to the same period last year. The Board recommends the payment of a final dividend for the Year at HK7.0 cents per share.Business Overview and ProspectsDuring the Year, revenue from cleaning services as the Group’s core business amounted to approximately HK$1,896.5 million, accounting for approximately 78.2% of the Group’s total revenue. The Group’s cleaning services cover various scenarios, including for Government streets, markets, police stations, fire stations, leisure venues, hospitals and clinics. In addition, the Group provides cleaning services for numerous different places such as universities, large exhibition centers, Hong Kong International Airport, housing estates and private institutions.During the Year, the Group successfully awarded a 3-year contract from the Marine Department of the Government for approximately HK$150 million for the provision of “Marine Refuse Cleansing and Disposal Services in the Eastern waters of Hong Kong”. This contract marks a significant milestone for Baguio, as it represents a strategic expansion of its service portfolio from land to sea, further strengthening its leading position in Hong Kong’s integrated environmental services market. Under the contract, Baguio delivers comprehensive marine refuse cleansing and ship refuse collection services in the Eastern waters of Hong Kong starting from 1 October 2025 including, but not limited to: Victoria Harbour, Central, Sheung Wan, Causeway Bay, Tsim Sha Tsui, Yau Ma Tei, Cheung Sha Wan, Shau Kei Wan, Kwun Tong, Sai Kung, Tolo Harbour and Tai Po. Winning this contract signifies strong market recognition of Baguio’s outstanding performance over the past 46 years. The Group will seamlessly extend its professional standards and operational efficiency in land-based waste management to the marine environment, striving to safeguard Hong Kong’s valuable marine ecosystem and present a cleaner, more beautiful Victoria Harbour to both residents and tourists.Waste management and recycling business recorded revenue of approximately HK$277.8 million, accounting for approximately 11.5% of the Group’s total revenue. The gross profit margin of the waste management and recycling business increased from 11.6% for the same period last year to 15.0%, driving the gross profit of this business up by approximately 25.2% to approximately HK$41.9 million, mainly due to the Government’s proactive promotion of recycling and the substantial expansion of the network of recycling spots, including those for food waste, which facilitated public participation and effectively stimulated collection, and the contribution from the green technology business.The Group continued to provide Government-related waste collection services to five districts, serving a population of approximately 1.6 million.In terms of recycling, the Group is contracted by the Environmental Protection Department (“EPD”) of the Government to provide collection services for thousands of recycling spots (including plastics, glass bottles, metals, waste paper and food waste) across Hong Kong. During the Year, the Group provided collection services for recycling bins in public places and schools. Baguio also provides collection services for Recycling Stations of “GREEN@COMMUNITY”, recycling stores and smart recycling machines, and other institutions in Hong Kong. In addition, Baguio also provides the Government with glass bottles collection and management services and food waste collection services in several districts in Hong Kong, and is one of the market leaders. In addition, during the Year, the Group was successfully awarded two 35-month contracts from the EPD, with a total value of approximately HK$43 million. During the Year, the Group was responsible for operating the “GREEN@Tai Wo” and “GREEN@Po Lam” recycling stores, and collaborated with nearby buildings, organizations, and community stakeholders to establish and operate fixed and mobile recycling spots for waste collection, provide community recycling support to facilitate citizens, and promote and educate the public on waste sorting and recycling in the community to strengthen citizens’ recycling habits.As a leading environmental services provider in Hong Kong, the Group provides integrated environmental management solutions including waste management, smart recycling and professional landscaping services to Kai Tak Sports Park, which hosts major sports events and concerts. With excellent environmental protection technologies and experience in operating large-scale international venues, the Group has fully demonstrated its strength in undertaking large-scale international programmes and delivering high-quality services. During the Year, the Group also provided waste recycling services for various Lunar New Year fairs across Hong Kong Island, Kowloon and the New Territories.Regarding green technology business, the Group won a new contract in relation to the development and supply of a new generation of solar-powered compacting refuse bins to the Government. This innovative product is designed with an auto-sensing inlet and indicator lights, and under its sealed design, it is equipped with devices for ventilation, lighting, and deodorization. Meanwhile, it is equipped with a big data platform and wireless technology to monitor data in real time, enabling effective tracking of the status of waste collection points, strategic deployment of resources, optimization of operational efficiency, and enhanced planning for future initiatives. Furthermore, the solar-powered compacting refuse bins adopt solar panels and rely on renewable energy, which significantly reduces carbon emissions. They can be flexibly deployed in various scenarios, suitable for remote areas where there are no refuse collection points. This product is expected to be gradually launched into the market in 2026.The Group seizes the opportunity of smart city development and has been committed to expanding its market share of smart recycling in recent years. Currently, Baguio’s smart recycling products, such as smart recycling machines, smart food waste recycling machines, and smart balances, have been deployed in different places across Hong Kong, including Government venues and schools, private housing estates, commercial buildings, theme parks, large-scale exhibition venues, and sports stadiums. These products provide the public with convenient recycling services 24 hours a day and help increase Hong Kong’s overall recycling volume.In partnership with Jardine Engineering Corporation Limited, the Pilot Biochar Production Plant at the EcoPark in Tuen Mun converts yard waste into high-quality biochar with pyrolysis technology for various applications, the production plant effectively “turns waste into useful resources”.As for the landscaping business, the Group provides landscaping services for a wide range of clients, including large private residences, Government premises, schools, shopping malls, hotels, Hong Kong Housing Authority, Hospital Authority, Hong Kong Jockey Club, Hong Kong Science Park, the University of Hong Kong, Hong Kong University of Science and Technology, Hong Kong Wetland Park, as well as 33 sports turf venues under the Leisure and Cultural Services Department, etc. During the Year, the Group provided landscaping services for Kai Tak Sports Park, Hong Kong International Airport, Hong Kong-Shenzhen Innovation and Technology Park, Nano Parks, the Tung Chung New Town Extension (West), Hung Shui Kiu/Ha Tsuen New Development Area and the ventilation building at the eastern portal of the Tseung Kwan O – Lam Tin Tunnel.For pest management business, the Group provided pest management services for venues in the Tsuen Wan District during the Year. In addition, the Group provided pest and rodent control services for hospitals, clinics and the headquarters of the Kowloon East, Kowloon Central and Kowloon West Clusters under the Hospital Authority. The Group also continued to provide termite control and monitoring services for 24 temples under the Chinese Temples Committee.The Promotion of Recycling and Proper Disposal of Products (Miscellaneous Amendments) Bill 2025 submitted by the Government was passed by the Legislative Council during the Year. This bill establishes a common legal framework for producer responsibility scheme applicable to different products. Under this framework, the Government plans to submit the producer responsibility scheme on plastic beverage containers and beverage cartons in 2026. The scheme encourages citizens to return used containers for recycling to earn rebate, which will help significantly increase the recycling rate. Benefiting from the scheme, Baguio’s recycling volume is expected to be directly driven up, providing attractive returns for the Group’s long-term investments in recycling services and competitive barriers.The Government is actively developing the Northern Metropolis. Four new development areas include Kwu Tung North/ Fanling North, Hung Shui Kiu/Ha Tsuen, Yuen Long South, and San Tin Technopole are under construction. The Government has resumed more than 400 hectares of private land within these four new development areas, completed land levelling for 80 hectares, and is progressively handing over these lands to relevant departments for building road and railway infrastructure, public and private housing, schools, public markets, ecological conservation, as well as development of innovation and technology industry. The Group believes that this will bring opportunities for many of its core businesses.Looking forward, the Group will continue to increase the market share of its core businesses and proactively engage in expansion in Hong Kong and beyond. Meanwhile, in line with the development of the Group, it will actively explore potential mergers and acquisitions, joint ventures or new business projects to accelerate future business growth and deliver substantial and long-term returns to shareholders.For details of the Group's 2025 annual results announcement, please visit the following website: https://www.baguio.com.hk/en/investor/notices/About Baguio Green GroupEstablished in 1980, Baguio Green Group (Stock code: 01397.HK) is one of Hong Kong’s largest integrated environmental management solution providers. It provides a full spectrum of professional services including professional cleaning, waste collection & recycling, waste management, green technology, green products, horticulture & landscaping, and pest control. The Group delivers innovative environmental solutions using the latest technologies to serve a wide range of customers in various sectors including Government departments, statutory organizations and multinational corporations. Fully committed to ESG, the Group works relentlessly to advance sustainable development and create a cleaner, greener, healthier city for a greener tomorrow. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 碧瑶绿色集团有限公司 （"碧瑶"或"集团"；股份编号：01397.HK）欣然宣布截至2025年12月31日止年度（"年内"）之全年业绩。年内，集团收益约为24.2亿港元，较去年同期减少约6.9%。年内纯利约为9,700万港元，较去年同期增加约72.0%。董事会建议派付本年度的末期股息每股7.0港仙。业务回顾及展望年内，清洁作为集团的核心业务，收益约19.0亿港元，占集团总收益约78.2%。集团的清洁服务涵盖不同场景，包括为政府辖下街道、街市、警局、消防局、康乐场地、医院及诊所提供清洁服务。此外，集团亦为大学、大型展览中心、香港国际机场、屋苑及私人机构等众多不同场所提供清洁服务。集团于年内成功中标政府海事处一份为期三年总值约1.5亿港元的"香港东部水域海上垃圾清理及处理服务"合约。此合约标志着碧瑶的服务版图，成功由陆地策略性拓展至海洋，为集团业务发展的重要里程碑，进一步巩固其在香港综合环境服务市场的领导地位。根据合约，碧瑶自2025年10月1日起，于香港东部水域包括但不限于维多利亚港、中环、上环、铜锣湾、尖沙咀、油麻地、长沙湾、筲箕湾、观塘、西贡、吐露港及大埔等地区，提供全面的海上清洁及船只生活垃圾收集服务。获得此合约，代表市场充份肯定碧瑶成立46年来的卓越表现。集团将其陆上废物管理的专业标准与营运效率无缝延伸至海上，致力守护香港珍贵的海洋生态环境，为市民及旅客呈现一个更洁净、更美丽的维多利亚港。废物管理及回收业务于年内收益为约2.8亿港元，占集团总收益约11.5%。废物管理及回收业务的毛利率由去年同期11.6%，增加至15.0%，拉动该业务毛利上升约25.2%，至约4,200万港元，主要受惠于政府积极推动回收，大幅扩展包括厨余的回收点网络，便利市民参与并有效刺激收集量，及绿色科技业务所带动。集团继续为政府辖下的五区提供废物收集服务，服务人口约160万。回收方面，集团作为政府环境保护署（"环保署"）服务承办商，为香港数千个回收点提供收集服务（包括塑料、玻璃樽、金属、废纸及厨余）。集团于年内为公共场所及学校的回收箱提供收集服务。此外，碧瑶亦为香港众多"绿在区区"回收环保站、回收便利点、智能回收机及不同机构提供回收服务。另外，碧瑶为政府于香港多区负责玻璃容器收集及处理，以及厨余收集，为市场领导者之一。此外，集团于年内成功中标环保署两份为期35个月总值港币约4,300万港元的合约。年内，集团负责营运「绿在太和」及「绿在宝琳」的回收便利点，以及与邻近大厦、机构及小区持份者合作，建立及营运固定及流动回收点进行收集，提供便利市民的小区回收支持，以及在小区推动和教育市民分类回收，强化市民回收习惯。集团作为香港领先的环境服务龙头，为专门举办大型体育赛事及演唱会的启德体育园，提供废物管理、智能回收及专业园艺工程的综合环境管理解决方案。凭借卓越的环保技术与大型国际场馆营运经验，充分展示了集团在承接国际级大型项目及高规格服务方面的实力。年内，集团更为香港、九龙及新界等多个年宵市场提供废物回收服务。绿色科技业务方面，集团赢得新合约，为政府研发及供应新一代太阳能废物压缩箱。此创新产品设计具有自动感应投入口及指示灯，在密封式设计下加装通风、照明及除臭等装置。同时配备大数据平台及无线技术实时监控数据，有效追踪废物收集点的状态，策略地部署资源，优化运作效率，并加强对未来措施的规划。此外，太阳能废物压缩箱采用光伏板，依靠可再生能源，大大减低碳排放，可灵活配置于不同场景，适合没有垃圾收集站的偏远地区。此产品预计于2026年陆续推出市场。集团把握智慧城市发展的契机，近年致力扩大智能回收的市场份额。目前碧瑶智能回收产品，例如：智能回收机、智能厨余回收机及智能磅等已遍及香港不同角落，包括各政府场地及学校、私人屋苑、商业大厦、主题乐园、大型展覧及体育场馆等。每日24小时为市民提供便捷的回收体验，并有助提升香港整体回收量。集团与怡和机器有限公司合作位于香港屯门环保园的生物炭工厂通过热解技术将园林废料转化为高质量生物炭以作各种应用，从而达到"转废为材"的目的。园艺方面，客户涵盖大型私人住宅、政府处所、学校、商场、酒店、香港房屋委员会、香港医院管理局、香港赛马会、香港科学园、香港大学、香港科技大学、香港湿地公园及康乐及文化事务署辖下33个运动草地场地提供草地护养人员服务等。集团年内为启德体育园、香港国际机场、港深创新及科技园、微型公园、东涌西新发展区、洪水桥╱厦村新发展区和将蓝隧道东面排风口大楼提供园艺工程。虫害管理方面，集团年内为荃湾区政府辖下场地提供虫害管理服务。此外，集团为医管局辖下九龙东、九龙中及九龙西联网各医院诊所及总部提供灭虫灭鼠服务，同时继续为华人庙宇委员会辖下24间庙宇，提供白蚁防治及监测服务。政府提交的《2025年促进循环再造及妥善处置产品（杂项修订）条例草案》于年内获立法会通过，为生产者责任计划订立适用于不同产品的共同法律框架。在此框架下，政府计划于2026年提交有关塑料饮料容器及纸包饮品盒生产者责任计划。此计划鼓励市民将使用完的容器交回作循环再造，从而获取回赠，有助大大增加回收率。受益于该计划，预计将直接拉动碧瑶的回收量，为集团多年来于回收服务建设的投资及竞争壁垒，提供吸引回报。政府正全速发展北部都会区，其中四个新发展区，包括古洞北╱粉岭北、洪水桥╱厦村、元朗南及新田科技城已进入施工阶段。政府已经在四个新发展区收回逾400公顷私人土地，完成平整80公顷土地并陆续将这些土地交付部门兴建道路铁路基建、公私营房屋、学校、公众街市、生态保育，以至发展创科产业，相信将为集团多个核心业务带来契机。展望未来，集团在致力提高各核心业务的市场份额的同时，将积极于香港及以外地区扩张。同时因应集团的发展，适时寻找潜在的并购、合营、或新业务项目，加速未来业务增长，为股东缔造可观及长远回报。有关集团2025年度业绩公告详情，请浏览以下网址：https://www.baguio.com.hk/zh-hant/investor/notices/碧瑶绿色集团简介碧瑶绿色集团（股份代号：01397.HK）成立于 1980 年，为香港最大的综合环境管理方案供货商之一，提供环卫保洁、资源回收、循环再造、废物管理、绿色科技、绿色产品、园艺绿化工程及害虫防治等。集团应用最新科技，提供创新环境解决方案，为不同领域的客户提供服务，包括政府部门、各大机构及跨国企业。集团努力不懈地提升环境、社会及管治（ESG）的表现，以推进集团的可持续发展，为了更绿的明天，实现将香港推动成为更清洁、更绿色、更健康城市的愿景。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 今日，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"或"公司"，股份代号：1788.HK）作为联席保荐人、保荐人兼整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人，成功助力浙江凯乐士科技集团股份有限公司（"凯乐士科技"，股份代号：2729. HK）在香港联交所主板上市，充分彰显国泰海通集团在跨境资本运作、高效整合资源、服务专精特新科技企业方面的综合实力。（国泰君安国际投行团队出席上市仪式）作为综合智能场内物流机器人龙头企业，凯乐士科技业务横跨29个不同行业及境内外19个国家及地区，两次获得国家工业和信息化部授予的国家级专精特新"小巨人"企业认证。本次发行最终定价为每股16.66港元，总发售股数达3,679.80万股，发行规模6.13亿港元。国际配售和香港公开发售录得踊跃认购，国际配售认购倍数达3.37倍，香港公开发售认购倍数达2153.26倍，充分展现了国际资本对中国高端制造的坚定信心，也生动展示了国泰海通服务科技创新与产业升级的成果。凯乐士科技的成功上市，是继龙旗科技（股票代码：9611.HK）、爱芯元智（股票代码：0600.HK）后，国泰君安国际在今年完成的第三个科技创新领域保荐项目，彰显了国泰君安国际作为一流投行的综合实力与卓越执行力。依托与总部国泰海通的协同优势，公司不仅展现出在复杂跨境资本运作中高效整合资源、精准把握市场窗口的专业能力，更凭借对"专精特新"及高端制造领域的深刻洞察，持续为中国科技企业走向国际资本市场搭建坚实桥梁。展望未来，国泰君安国际将继续秉持金融服务实体经济的初心，以更高水平的综合金融服务，助力更多中国优质企业扬帆远航，在全球资本市场书写新的篇章。关于凯乐士科技凯乐士科技是领先综合智能场内物流机器人提供商，拥有广泛的机器人技术能力及多元化的自主研发机器人产品组合，涵盖广泛采用的高度和有效载荷规格的核心场内物流功能。凯乐士科技在极窄巷道自主移动机器人及四向穿梭车等主要类别的尖端智能场内物流机器人的出货量处于领先地位。凯乐士业务横跨29个不同行业及境内外19个国家及地区，并且成功交付实施了超过1,600个项目，其下游客户涵盖各行各业的领先企业，包括医药、3C电子产品、新能源及汽车行业的领先企业。凭借立足中国，全球领先的长期战略，凯乐士科技将持续受益于中国企业出海的浪潮，成为中国企业出海的关键场内物流基础设施推动者。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK）,是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高品质、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的资讯请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

West Palm Beach, FL, Mar 24, 2026 - (ACN Newswire via SeaPRwire.com) - Global Polo, the entertainment subsidiary of USPA Global, continues its historic relationship with ESPN to showcase the sport of polo, which has expanded its reach to millions of households worldwide. The landmark relationship includes legendary ESPN commentator Chris Fowler hosting the USPA Gold Cup® Final on Mar. 29 for the first time, and the U.S. Open Polo Championship® Final on Apr. 26 for the second year, at the USPA National Polo Center in Palm Beach County, Florida, alongside veteran broadcasters Kenny Rice and Polo Hall-of-Famer Adam Snow.Legendary ESPN Commentator, Chris Fowler, at the USPA National Polo Center in Palm Beach County, FloridaPhoto Credit: Alex Pacheco"I've had the privilege of covering some of the most iconic events in sports, and what continues to draw me back to the sport of polo is the unique partnership between the polo player and polo pony, as well as the speed and intensity of competition at the highest level," said Fowler. "Hosting both the USPA Gold Cup and the U.S. Open Polo Championship allows me to share the energy and uniqueness of this beautiful sport with a broader ESPN audience.""There's nothing quite like seeing these world-class athletes and their equine partners compete in such a fast-paced, strategic game," Fowler added.The USPA Gold Cup, first played in 1974, is the second most important tournament in American polo, right next to the U.S. Open Polo Championship, which was first played in 1904. This year's competition will feature 10 elite teams competing at the highest level of the sport from March 4 - 29. The prestigious U.S. Open Polo Championship, played April 1 - 26, is widely recognized as a showcase for many of the world's top players and equine athletes and remains one of the most prestigious polo tournaments globally. Both tournaments have been played back-to-back since they arrived in Palm Beach County, Florida, in 2004. These highly rated polo competitions take place on the U.S. Polo Assn. Stadium Field One at the USPA National Polo Center (NPC) in Wellington, Florida.Coverage of the USPA Gold Cup final in early April, followed by the U.S. Open Polo Championship final match in May, will be available on multiple ESPN platforms, including ESPN2. Check your local listings for specific airtimes."Our long-term relationship with ESPN continues to elevate the sport of polo, the U.S. Polo Assn. brand, and the global momentum behind it," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar global sport brand, U.S. Polo Assn. "Chris Fowler's return and expanded presence hosting both the USPA Gold Cup and the U.S. Open Polo Championship further strengthens the momentum and visibility of these world-class tournaments to a global audience.""Supported by ESPN, the sport of polo continues to garner interest from fans around the world," added Prince.Beyond live game coverage, ESPN platforms also feature new episodes of the two-time award-winning show, Breakaway: Presented by U.S. Polo Assn. produced by Global Polo. Viewers can follow exclusive behind-the-scenes coverage, player features, and championship highlights on Global Polo's YouTube channel, including special coverage tied to the USPA Gold Cup and the U.S. Open Polo Championship broadcasts."The United States Polo Association is delighted to see the continued growth of the sport through our relationship with ESPN," said Stewart Armstrong, Chairman of the United States Polo Association (USPA). "The USPA Gold Cup and the U.S. Open Polo Championship represent the highest level of competition at the USPA National Polo Center for the American season, and the increased visibility provided by ESPN underscores the athleticism, dedication, and tradition that define our sport."For the most up-to-date information and breaking news, sign up for the Polo Insider newsletter at globalpolo.com and visit uspolo.org.About ESPNESPN, the world's leading multiplatform sports entertainment brand, features seven U.S. television networks, the leading sports app, direct-to-consumer ESPN+, leading social and digital platforms, ESPN.com, ESPN Audio, endeavors on every continent around the world, and more.About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sportsin India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth and sport content. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.About the United States Polo Association® (USPA)The United States Polo Association® is organized and exists for the purposes of promoting the game of polo; coordinating the activities of its member clubs and registered player members; arranging and supervising polo tournaments, competitions, and games; and providing rules, handicaps, and tournament conditions for those events. Its overarching goals are improving the sport and promoting the safety and welfare of its human and equine participants. Founded in 1890, the USPA is the largest voluntary sports organization in North America for the sport of polo. The USPA is currently made up of more than 200 member clubs and over 5,000 registered player members. It annually awards and oversees roughly 50 national tournaments hosted by its member clubs. For more information, please visit uspolo.org.For Additional Information, Contact:Shannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comStacey Kovalsky - VP, Global PR and CommunicationsPhone +001.954.673.1331 - E-mail: skovalsky@uspagl.comChristine Calcagno - Sr. Publicist, ESPN CommunicationsPhone +001.959.216.8036 - E-mail: christine.b.calcagno@espn.comSOURCE: USPA Global Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

佛罗里达州西棕榈滩, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - USPA Global旗下娱乐子公司Global Polo延续与ESPN的深厚合作关系，继续向全球数百万家庭推广马球运动。此次具有里程碑意义的合作包括：ESPN传奇解说员克里斯·福勒将首次主持3月29日的USPA金杯赛®决赛，并连续第二年主持4月26日的美国公开马球锦标赛®决赛。赛事将在佛罗里达州棕榈滩县的USPA国家马球中心举行，届时他将与资深播音员肯尼·赖斯以及马球名人堂成员亚当·斯诺共同主持。Legendary ESPN Commentator, Chris Fowler, at the USPA National Polo Center in Palm Beach County, FloridaPhoto Credit: Alex Pacheco“我有幸报道过体育界一些最具标志性的赛事，而让我不断回归马球运动的，是马球运动员与马球马之间独特的伙伴关系，以及最高水平比赛中展现的速度与激烈程度，”福勒表示。“主持USPA金杯赛和美国公开马球锦标赛，让我能够将这项美丽运动的活力与独特性分享给更广泛的ESPN观众。”“没有什么能比得上亲眼目睹这些世界级运动员与他们的马匹伙伴在这项节奏快、充满策略的比赛中竞技的体验，”福勒补充道。USPA金杯赛始于1974年，是美国马球界仅次于美国公开马球锦标赛（始于1904年）的第二大赛事。今年的赛事将于3月4日至29日举行，届时将有10支精英队伍在最高水平的竞技中一决高下。而备受瞩目的美国公开马球锦标赛将于4月1日至26日举行，该赛事被公认为众多世界顶级球员和马匹的展示舞台，至今仍是全球最负盛名的马球赛事之一。自2004年落户佛罗里达州棕榈滩县以来，这两项赛事便一直接连举行。这些备受瞩目的马球赛事将在佛罗里达州韦灵顿的美国马球协会（USPA）国家马球中心（NPC）内的美国马球协会体育场一号场举行。4月初的USPA金杯赛决赛以及5月的美国公开马球锦标赛决赛，都将在ESPN2等ESPN旗下多个平台进行转播。具体播出时间请查阅当地节目表。“我们与ESPN的长期合作关系持续推动着马球运动、U.S. Polo Assn.品牌及其背后的全球发展势头，”管理着价值数十亿美元的全球体育品牌U.S. Polo Assn.的公司——USPA Global总裁兼首席执行官J·迈克尔·普林斯表示。“克里斯·福勒的回归以及他将同时主持USPA金杯赛和美国公开马球锦标赛的扩展参与，进一步增强了这些世界级赛事在全球观众中的势头和知名度。”“在ESPN的支持下，马球运动持续吸引着全球粉丝的关注，”普林斯补充道。除赛事直播外，ESPN平台还将播出由Global Polo制作、两度获奖的节目《Breakaway：U.S. Polo Assn.呈现》的新一季内容。观众可通过Global Polo的YouTube频道观看独家幕后花絮、球员特写及锦标赛精彩集锦，其中包括与USPA金杯赛和美国公开马球锦标赛转播相关的特别报道。“美国马球协会（USPA）很高兴看到这项运动通过与ESPN的合作持续发展，”美国马球协会（USPA）主席斯图尔特·阿姆斯特朗表示。“USPA金杯赛和美国公开马球锦标赛代表了美国赛季中USPA国家马球中心最高水平的竞技，而ESPN带来的更高曝光度，彰显了定义我们这项运动的运动精神、奉献精神和传统。”如需获取最新资讯和突发新闻，请访问 globalpolo.com 订阅《马球内幕》通讯，并浏览 uspolo.org。关于ESPN作为全球领先的多平台体育娱乐品牌，ESPN旗下拥有七家美国电视网络、领先的体育应用程序、面向消费者的流媒体服务ESPN+、领先的社交及数字平台、ESPN.com、ESPN Audio，业务遍及全球各大洲，此外还有更多业务。关于 U.S. Polo Assn. 和 USPA GlobalU.S. Polo Assn. 是美国马球协会（USPA）的官方运动品牌。USPA 成立于 1890 年，是美国规模最大的马球俱乐部和马球运动员协会。凭借数十亿美元的全球业务规模，以及通过1,200多家U.S. Polo Assn.零售店和数千个其他销售网点实现的全球分销网络，U.S. Polo Assn.为全球190多个国家的男女及儿童提供服装、配饰和鞋履。该品牌赞助了全球各大马球赛事，包括每年在棕榈滩的NPC举行的美国公开马球锦标赛®——这是美国最顶级的马球锦标赛。通过与美国ESPN、欧洲TNT和Eurosport以及印度Star Sports达成的历史性合作，由U.S. Polo Assn.赞助的数项世界顶级马球锦标赛现已实现电视转播，使全球数百万体育迷首次得以欣赏这项激动人心的运动。据《License Global》报道，U.S. Polo Assn. 一直与 NFL、PGA 巡回赛和一级方程式赛车并列，被评为全球顶级体育授权商之一。此外，这一受运动启发的品牌因全球业务增长和体育内容而屡获国际奖项。凭借其作为全球品牌的巨大成功，U.S. Polo Assn. 不仅登上了《福布斯》、《财富》、《现代零售》和《GQ》等杂志，还出现在雅虎财经和彭博社等全球众多知名媒体上。如需了解更多信息，请访问 uspoloassnglobal.com 并关注 @uspoloassn。USPA Global是美国马球协会（USPA）的子公司，负责管理价值数十亿美元的运动品牌U.S. Polo Assn.。USPA Global还管理其子公司Global Polo，后者是全球马球运动内容的领导者。如需了解更多信息，请访问globalpolo.com或YouTube上的Global Polo频道。关于美国马球协会®（USPA）美国马球协会®的成立宗旨在于推广马球运动；协调其会员俱乐部及注册球员会员的活动；组织并监督马球锦标赛、竞赛及比赛；并为相关赛事提供规则、让分制度及比赛条款。其总体目标是提升该项运动水平，并保障人类及马匹参与者的安全与福祉。USPA成立于1890年，是北美地区规模最大的马球志愿体育组织。目前，USPA拥有超过200家会员俱乐部和5,000多名注册球员会员。该协会每年主办并监督由其会员俱乐部承办的约50场全国性赛事。如需了解更多信息，请访问uspolo.org。如需更多信息，请联系：香农·斯蒂尔森（Shannon Stilson）——体育营销与媒体副总裁 电话 +001.561.227.6994 - 电子邮件：sstilson@uspagl.com斯泰西·科瓦尔斯基（Stacey Kovalsky）——全球公关与传播副总裁 电话 +001.954.673.1331 - 电子邮件：skovalsky@uspagl.com克里斯汀·卡尔卡尼奥 - ESPN传播部高级公关专员 电话 +001.959.216.8036 - 电子邮件：christine.b.calcagno@espn.com来源：USPA Global Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 24, 2026 - (ACN Newswire via SeaPRwire.com) - SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”; stock code: 03681.HK) is pleased to announce its annual results for the year ended 31 December 2025 (the “Year”).During the year, loss for the year was approximately RMB105.0 million, decreased by RMB80.1 million from RMB185.1 million for the year ended 31 December 2024. The Company focused on SM17 Phase 1b clinical, transformation bridging study and preparation of Phase 2 clinical trial in 2025, of which the cost was less than large scale clinical studies in 2024. As at 31 December 2025, total funding available to use was approximately RMB351.5 million, representing a significant increase compared to RMB141.4 million as at 31 December 2024. During the year, the Group gained support from well-known institutional investors including Foresight, Fullgoal, and E Fund, completed two rounds of new share subscriptions under general mandate and successfully raised an aggregate amount of approximately HK$493.7 million in net proceeds. This drove net cash flows from financing activities for the Reporting Period to approximately RMB329.4 million, providing sufficient funding to support subsequent R&D and clinical advancement.SM17 Achieves Multiple BreakthroughsSM17 is a global first-in-class humanised monoclonal antibody (mAb) targeting the receptor for IL-25, which is capable of modulating Type II allergic reaction by targeting the receptor of a critical “alarmin” molecule interleukin-25 (IL-25). The compound has the potential for treating atopic dermatitis (AD), Inflammatory Bowel Disease (IBD), asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and idiopathic pulmonary fibrosis (IPF).In the field of atopic dermatitis (AD), SM17 precisely targets upstream drivers of Type 2 immune responses by blocking IL-25, a key “alarmin” cytokine, thereby suppressing the inflammatory cascade at its source. While currently approved AD therapies, including biologics, can significantly improve Eczema Area and Severity Index (EASI) scores and patients’ quality of life, current drugs under development or on the market cannot simultaneously meet the clinical needs for rapid itch relief, skin lesion recovery, and good safety profiles, indicating substantial unmet market demand. SM17’s key innovation lies in its upstream modulation of the Th2 inflammatory cytokine pathway via IL-25 receptor inhibition, thereby suppressing multiple downstream pathogenic signaling pathways. Preclinical studies have demonstrated its potential for rapid itch relief, significant skin lesion recovery, and a favorable safety profile, directly addressing the key limitations of current therapies.In April 2025, SM17 achieved encouraging positive results in a Phase 1b study in China for the treatment of moderate to severe atopic dermatitis (AD): 12-week topline data after unblinding showed that in the high dose group, 91.7% of patients achieved pruritus relief (NRS-4), 75% achieved skin healing (EASI 75), and 41.7% achieved clear or almost clear signs of AD (IGA0/1). These results significantly outperform IL-4/IL-13 monoclonal antibodies and demonstrate a significantly better safety and tolerability profile than Janus Kinase inhibitors (JAK inhibitors), making SM17 potentially the first-in-class and best-in-class therapeutics which can simultaneously achieve rapid onset of action on pruritic relief, skin healing with a good safety profile. Study results of SM17 were published in various leading international journals. Phase 2 clinical trial for AD is expected to be entered into as early as mid-2026.On 11 December 2025, an Investigational New Drug application (“IND”) for SM17 in the indication of IBD was filed with and accepted by the Center for Drug Evaluation (the “CDE”) of the National Medical Products Administration of China (“NMPA”), and the IND was subsequently approved in February 2026. This IND submission represents an important step toward expanding SM17’s therapeutic scope beyond AD to IBD, including Crohn’s disease (“CD”) and ulcerative colitis (“UC”), which are chronic, debilitating conditions with significant unmet medical needs. In October 2025, the first cohort of healthy subjects was dosed in a Phase 1 bridging clinical trial for the route of administration conversion in China. As of 31 December 2025, a total of 30 healthy subjects had been enrolled and our follow-up visits for all healthy subjects were completed in February 2026. This bridging study is expected to be completed by the second quarter of 2026. Data from this study will be leveraged to support the progression of the IBD indication directly to Phase 2 clinical development.Early-Stage Pipelines Drive Continuous Innovation GrowthIn terms of early-stage pipeline development, the Company continues to make steady progress. In June 2025, Its partner, Everest Medicines, has announced positive results from the Phase Ib/IIa clinical trial of EVER001 (SinoMab’s SN1011) for the treatment of primary membranous nephropathy (PMN), further enhancing the commercial value of the pipeline.At the same time, multiple early-stage R&D programs are progressing steadily. Anti-CGC antibody is an in-house developed, first-in-class humanised anti-γc antibody. Our in vitro assays suggested that our antibody could suppress inflammation and autoimmunity driven B, T and NK cell activation. Animal studies demonstrated that our antibody could be a potential therapeutic agent for the treatment of vitiligo, alopecia areata and possibly other autoimmune diseases through the modulation of immune cell expansion, autoreactivity and tissue infiltration. We are currently in the process of CMC optimisation and toxicology studies for our antibody and plan to submit our IND application for the treatment of alopecia areata by the fourth quarter of 2026 at the earliest.Bispecific antibody candidate is a novel, bispecific antibody targeting Receptor activator of the nuclear factor kappa-B ligand (RANKL) and sclerostin for bone-related indications. bsAb processes differential mechanisms of action tailored for the treatment of osteoporosis. Our in-house in vitro and in vivo studies demonstrated our candidate to have enhanced efficacy over market-approved antibodies such as Denosumab and Romosozumab. We are currently in the process of optimising CMC and testing toxicity in non-human primates and plan to submit our IND application by the first half of 2027 at the earliest.Expanding Strategic Partnerships and Gaining Strong Industry RecognitionsIn August 2025, the Company entered into a comprehensive strategic cooperation agreement with Sun Yat-sen University Institute of Advanced Studies Hong Kong Limited (“SYSU-IAS”). Under the cooperation agreement, the Company enjoys direct access to SYSU-IAS’s comprehensive laboratory facilities and valuable data resources, as well as access to primate and non-primate animal studies supply resources, to accelerate the development of innovative drugs and promote the translation of scientific research into clinical applications worldwide. Furthermore, the Company is actively exploring the feasibility of using artificial intelligence (AI) technology for new target identification.In January 2026, the Company was invited to participate in the J.P. Morgan Healthcare Conference, where it shared its progress in the autoimmune field with multiple multinational pharmaceutical companies (MNCs) and investors.With the support of our strong R&D capabilities, extensive pipeline assets and refined operational management, we are thrilled to obtain renowned awards during the year, including the 2nd “New Quality Productive Forces Enterprise Award” jointly presented by the Greater Bay Area Family Office Association and the Hong Kong International Family Office Association, as well as the “Most Valuable Pharmaceutical Company Award” presented by Zhitong Finance.Dr. Shui On LEUNG, Executive Director, Chairman and Chief Executive Officer of SinoMab, comments: "In 2025, we demonstrated the global competitiveness of our innovative pipeline with solid clinical data. The outstanding performance of SM17 in AD and its indication expansion to IBD signify our continuous transition from single-product R&D to the realisation of platform value. Looking ahead to 2026, the biopharmaceutical industry has been accelerating into the “Biotech 3.0 Era”, which is characterised by innovation-driven development, multidisciplinary integration, and intelligent processes across the entire supply chain. We are well-positioned to capture the historic opportunity of the rapid growth of out-licensing deals in China’s biopharmaceutical industry, continue to advance the clinical development of our core pipelines, and deepen our international partnership footprint. Relying on our solid cash reserves, full-spectrum capabilities across the industry chain and the principle of differentiated innovation, we strive to maximize the returns of shareholders in the long run and provide life-changing breakthrough therapies for patients.”About SinoMab BioScience LimitedSinoMab BioScience Limited (Stock Code: 03681.HK) is a pioneer in the research and development of first-in-class and potential best-in-class therapeutic antibody drugs, focusing on autoimmune diseases, neurodegenerative disorders, and other debilitating diseases, committed to addressing unmet medical needs. SinoMab has consistently focused on developing therapeutic antibodies targeting novel targets and employing innovative mechanisms, aiming to achieve differentiated clinical outcomes in areas where existing therapies have shown limited efficacy. Its rich R&D pipeline includes: SM17, which has demonstrated exceptional anti-pruritic effects, skin clearance rates, and safety profiles in the treatment of AD, with potential applications in asthma and idiopathic pulmonary fibrosis (IPF); its flagship anti-CD22 antibody, Suciraslimab , which has been clinically validated for efficacy in rheumatoid arthritis (RA) and is currently undergoing clinical evaluation for systemic lupus erythematosus (SLE) and Alzheimer's disease; another innovative anti-CGC (common gamma chain) monoclonal antibody, which is preparing to enter clinical studies for the treatment of alopecia areata and vitiligo; and a bispecific monoclonal antibody developed by SinoMab that simultaneously stimulates bone growth and inhibits bone loss for the treatment of osteoporosis. With breakthrough efficacy as its core pursuit, SinoMab continuously redefines patient care standards and maintains a leading position in the field of breakthrough therapies. This press release is issued by Zhenzhuo Group on behalf of SinoMab BioScience Limited.Investor and Media InquiriesContact Person: Bunny LeeCitrus JiangWendy HuangPhone: (852) 5316 9995Email: ir_sinomab@zhenzhuoglobal.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 中国抗体制药有限公司（"中国抗体"或"公司"，连同旗下附属公司统称"集团"，股份代号：03681.HK）欣然公布截至2025年12月31日止年度（"年内"）的全年业绩。年内，公司亏损由截至2024年12月31日止年度的人民币1.85亿元减少人民币0.80亿元至约人民币1.05亿元，主要得益于公司聚焦SM17 1b期临床、剂型桥接研究及2期临床筹备，研发成本较2024年大规模临床研究有所下降。截至2025年12月31日，公司可动用资金总额约人民币3.52亿元，较上年同期的人民币1.41亿元显著增长。年内，集团获得睿远、富国、易方达等多家知名机构投资者支持，公司完成两轮股份配售，合计募集所得款项净额约4.93亿港元，带动融资活动所得现金流净额达人民币3.29亿元，为后续研发及临床推进提供了充足资金支持。核心产品SM17取得多项突破性进展SM17是全球首创（First-in-Class）的靶向IL-25受体的人源化单抗，通过靶向II型免疫核心"警戒素（Alarmin）"分子白细胞介素25（IL-25）受体，调节II型炎症反应。SM17具有治疗特应性皮炎（AD）、炎症性肠病（IBD）、哮喘、慢性鼻窦炎伴鼻息肉（CRSwNP）及特发性肺纤维化（IPF）的潜力。在特应性皮炎（AD）领域，SM17精准作用于II型免疫反应的上游，通过阻断被称作"警报素"的关键细胞因子IL-25，从源头上抑制导致AD的炎症级联反应。当前，已获批上市的AD疗法（包括生物制剂）虽然可以大大改善患者的湿疹面积和严重程度指数以及生活质量。然而目前在研在售药物无法同时满足快速起效止痒，皮损恢复，同时具备良好安全性的临床需求，市场尚存在巨大空间。SM17的创新之处在于，它通过靶向Th2炎性细胞因子通路上游（如IL-25受体），从而对下游信号通路的致病因子产生抑制效果，且在临床前研究中展现出快速止痒、显著修复皮损以及良好安全性的潜力，直击现有疗法痛点。2025年4月，SM17在中国治疗中重度特应性皮炎的1b期研究中，取得了令人鼓舞的积极结果：揭盲后的12周顶线数据显示，高剂量组的91.7%的患者实现瘙痒缓解指标（NRS-4），75%达到皮损恢复(EASI75)指标，41.7%达到完全或近乎完全清除AD症状指标（IGA 0/1）。该结果显著优于IL4/IL-13类单抗药物且安全性与耐受性显著优于Janus激酶抑制剂（JAK抑制剂），这使得SM17有望成为一款可同时实现快速止痒、皮肤损伤修复，且安全性表现优异的同类首创及同类最优疗法。SM17的研究成果已在多家国际顶级期刊发表。预计最早在2026年年中进入AD的2期临床试验。此外，SM17持续拓展出多个新的适应症，于本年度第二季度，SM17的适应症拓展进一步取得突破性进展。2025年12月11日，SM17用于治疗IBD的新药研究申请（"IND"）已提交予中国国家药品监督管理局（"中国国家药监局"）药品审评中心（"药品审评中心"），并已获受理，且IND随后于2026年2月获批。此次IND的提交，代表着SM17治疗范围从AD拓展至IBD的重要里程碑，涵盖克罗恩病（"CD"）及溃疡性结肠炎（"UC"）等慢性、衰竭性疾病，这些疾病存在显著未满足的医疗需求。于2025年10月，首组健康受试者已在中国给药途径转换之1期桥接临床研究中给药。截至2025年12月31日，合共三十名健康受试者已入组且对全部健康受试者之随访于2026年2月完成。该桥接研究预期于2026年第二季度前完成。该研究数据将用作支持IBD适应症的进展直接推进2期临床开发。早期在研管线布局提供持续创新动力在早期在研管线方面，公司持续取得积极进展。2025年6月合作伙伴云顶新耀公布了EVER001（中国抗体SN1011）用于治疗原发性膜性肾病（PMN）的1b/2a期临床试验的积极结果，进一步提升了管线的商业化价值。同时，公司多项早期研发项目稳步推进。其中，抗CGC抗体是一款内部开发的全球首创人源化抗γc抗体。动物研究显示，该抗体可能透过调节免疫细胞的扩增、自身反应性及组织浸润，成为治疗白癜风、斑秃，甚至其他自身免疫性疾病的潜在治疗药物。目前正在针对该抗体进行CMC优化及毒理学研究，并计划最早在2026年第四季度前提交其治疗斑秃的IND申请。双特异性抗体候选药物是一种新型双特异性抗体，靶向核因子kappa-B配体受体激活因子(RANKL)及骨硬化蛋白，治疗骨相关适应症。通过的内部体外及体内研究显示，相较于市售批准的抗体（如地诺单抗及罗莫珠单抗），该候选药物展现出更佳的疗效。目前正在进行CMC优化，并在非人灵长类动物中测试其毒性，并计划最早在2027年上半年前提交IND申请。协同推进战略合作与BD授权，荣获多项重磅荣誉公司于2025年8月与中山大学香港高等研究院有限公司（"SYSU-IAS"）签订全面战略合作协议，本公司可直接使用SYSUIAS完备的实验室设施与宝贵的数据资源，并获得包括灵长类及非灵长类实验动物在内的科研资源支持，加速创新药物研发进程，推动科研成果在全球范围内向临床应用转化。同时公司正积极探索运用人工智能(AI)技术开展新靶点发现的可行性。2026年1月，公司受邀参加摩根大通医疗健康大会（JPM大会）并与多家MNC、投资者分享了公司在自免领域的进展。依托雄厚的研发实力、丰富的管线储备及精细化运营管理，公司于本年度荣获多项重磅荣誉，包括粤港澳大湾区家族办公室协会与香港国际家族办公室协会联合颁发的第二届"新质生产力企业大奖"，以及智通财经授予的"最具价值医药公司奖"。中国抗体董事长、执行董事兼首席执行官梁瑞安博士表示："2025年，我们凭借扎实的临床数据证明了创新管线的全球竞争力，SM17在AD中的优异表现及其向IBD的拓展，标志着我们正从单一产品研发迈向平台价值的持续兑现。展望2026年，生物医药行业正加速迈入‘生物技术3.0时代’，创新驱动、多学科融合及全产业链智能化将成为核心发展方向。我们将把握中国生物医药对外授权高速增长的历史机遇，持续推进核心管线的临床开发，深化国际合作布局。依托坚实的现金储备、完善的产业链能力以及差异化创新优势，为股东创造长期价值，并为患者提供具有突破性的治疗方案。"关于中国抗体制药有限公司中国抗体制药有限公司（股份代号：03681.HK）是首创新药及潜在同类最佳抗体药物研发领域的开拓者，专注于自身免疫性疾病、以及由此导致的神经系统疾病及其他难治的耗损性疾病，致力于解决未被满足的医疗需求。中国抗体始终致力于开发针对全新靶点及通过创新机制的治疗性抗体，旨在现有疗法效果不佳的领域实现差异化临床成果。其丰富的研发管线包括：SM17在AD治疗中展现出卓越的止痒效果、皮肤清除率及安全性，同时在哮喘和特发性肺纤维化（IPF）领域具有应用潜力；其旗舰抗CD22舒西利单抗，除了临床验证对类风湿关节炎（RA）具有临床疗效外，目前正针对系统性红斑狼疮（SLE）和阿尔茨海默病开展临床评估；另一款抗CGC（共同γ链）创新单抗，正准备进入治疗斑秃和白癜风的临床研究；中国抗体亦研发了一款能同时刺激骨骼生长及抑制骨骼流失、治疗骨质疏松症的双特异性抗体。中国抗体以突破性疗效为核心追求，不断重新定义患者护理标准，稳居突破性疗法领域的领军地位。此新闻稿由真灼财经代中国抗体制药有限公司发布投资者及媒体查询联络人：Bunny LeeCitrus JiangWendy Huang电话：（852）5316 9995电邮：ir_sinomab@zhenzhuoglobal.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 这家承载356年品牌传承的中医医疗服务龙头近日正在港股招股，背靠"老字号"，补齐了同仁堂集团"制药-零售-医养"大健康生态圈的最后一块拼图 。本次全球发售1.08亿股，其中香港公开发售约10%，国际发售约90%。基石投资者已锁定占发行规模逾46%，基石占比接近最高限额。机构真金白银入场：基石比例高，机构参与热度足数据是最诚实的信号。据招股书披露，基石投资者航空港科技资本（香港）及Aurora SF将按发售价认购总金额约3.89亿港元的股份，占全球发售规模逾46%，这一比例在近期港股IPO中处于较高水平。基石锁定比例高意味着上市后可流通筹码有限，对二级市场价格支撑更强。此外，基石锁定期超过传统规定的6个月，进一步增强了市场的预期。获客成本极低：仅为同行业的六十分之一在医疗服务行业，获客成本是决定盈利天花板的关键变量。同仁堂医养背靠始创于1669年的"同仁堂"金字招牌，品牌壁垒的经济价值可以用一个数字概括：2024年推广费占收入比例仅约0.2%。然而就诊人次却从2022年的132.1万飙升至2024年的297.7万，CAGR高达50.1%。2025年前9月达253.6万，同比再增21.5%。会员从43.6万增至76.7万（2025年9月），复购粘性强劲。随着收入规模扩大，同行需要花在营销上的每一分钱，对同仁堂医养而言几乎都可以直接转化为利润。这是任何竞争对手都无法在短期内复制的护城河。盈利拐点已确立：经调整净利润增长29%对于处于上市窗口的成长型企业，投资者最关心的是：盈利趋势是向上还是向下？答案很明确——向上，且加速。财务数据显示，公司已展现出稳健的盈利能力。2022年至2024年，公司已由亏损923万元转为盈利4620万元，经调整净利润达6173万元，增长达到29%；毛利同期从1.43亿元增至2.22亿元，年复合增长率为 24.8%；2024年现金转化率87.2%，有息债务占比仅11.56%，持有现金2.25亿元，盈利质量显著提升 。同仁堂医养当前的发展阶段与固生堂上市时高度相似，盈利能力刚进入释放通道，增长最快的阶段可能尚未到来。复制增长阶段：计划新增20家医疗机构中医医疗服务是业绩基本盘，公司已构建包含25家医疗机构的分级诊疗网络，其中自有医疗机构12家，管理医疗机构12家，此外还有1家互联网医院提供线上诊疗服务。截至2024年就诊人数约300万人，CAGR高达50.12%；2025年前9月约253.6万，同比再增21.5%；会员数量约74万人，合作药店约500余家。作为同仁堂集团打开增长空间的核心业务，医疗服务板块规模还需要更强力的支持与扩张。根据其募集资金使用披露，该公司计划新收购5家医疗机构、以轻资产的方式新建5家医疗机构，并额外向5-10家医疗机构提供管理服务。可见，其未来快速扩张的战略清晰，"收购+轻资产新建+管理输出"三路径协同。非"名医驱动"： 依靠标准化"体系驱动"对中医医疗服务企业而言，最大的成长瓶颈在于"名医能否复制"。同仁堂医养正在用一套体系化的方法论回答这个问题。公司向上游延伸，自建了供应链体系，完成了端到端的产业链闭环。除药品外，健康产品销售也实现了品牌价值的商业化变现。公司已获授权在浙江省独家销售同仁堂爆款安宫牛黄丸系列产品，截至最后实际可行日期，公司已向超过4000家机构客户销售健康产品及其他产品。此外，公司将云数字化系统扎根进网络内每一家医疗机构，通过实时数据分析及管理，用智能系统代替"院长"，正在向"人机协作式"新型连锁医疗管理方式过渡。让增长不再完全依赖于个别名医的"人治"，而是依托可复制的运营体系、数字化中台和人才培养机制，实现规模化、标准化扩张。AI+中医：医药数据壁垒深厚作为同仁堂集团在中医服务领域唯一战略性布局的载体，同仁堂医养正站在传统中医与人工智能交汇的历史拐点上 。同仁堂集团近期积极推动AI技术在中医药领域的落地应用，已与小米联合打造"AI智能中医药健康服务智能体"，将传统中医智慧与现代AI技术深度融合，形成"咨询—建议—服务—购药"的服务闭环 。展望未来，万亿规模的中医医疗服务市场正迎来龙头整合的黄金窗口期。同仁堂医养以多轮驱动的发展模式、稳健的财务基础及AI技术的前瞻布局，不仅完成了老字号资本版图的最后一块"拼图"，更开启了中医服务与前沿科技深度融合的新纪元。随着上市募集资金的到位，相信同仁堂医养有望加速推进核心业务的全面AI转型，在万亿级中医医疗服务市场中持续巩固龙头地位，引领行业迈向智能化新时代。转载自格隆汇 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 中国领先的技术驱动移动出行平台嘀嗒出行（“嘀嗒”或“公司”，股票代码：02559.HK）公布了截至2025年12月31日止年度的经审计综合年度业绩。财务亮点：-截至2025年12月31日止年度，收入为人民币5.02亿元，2024年同期为7.87亿元。-截至2025年12月31日止年度，毛利为人民币3.33亿元，2024年同期为5.67亿元。-截至2025年12月31日止年度，净利润为人民币1.30亿元，2024年同期为10.04亿元。-截至2025年12月31日止年度，经调整净利润（非国际财务报告准则计量）为人民币1.38亿元，而2024年同期为2.21亿元。运营亮点：-截至2025年12月31日止年度，交易总额达人民币47亿元，订单总数达到8090万。-截至2025年12月31日，注册用户数超过4.15亿。-截至2025年12月31日，认证私家车主数量达到约2100万。业务展望：出行相关业务2025年是嘀嗒出行从专注于顺风车的平台，向更为综合的出行及车辆服务平台转型的关键之年。2025年，嘀嗒出行推出了聚合打车业务，来进一步丰富平台的出行场景，使“中短途+立即出发“的即时出行需求与顺风车”中长途+预约出行“的场景形成有效互补，增强用户在不同出行决策场景下的选择弹性。嘀嗒出行还开启了二手车交易线索业务，拓展车辆全生命周期的业务范围，并提升车主生态的用户参与度。嘀嗒出行认为，顺风车在中国仍处于早期发展阶段，有潜在的巨大市场需求还未被充分释放，而顺风车的益处还未被完全认知。嘀嗒出行将持续致力于创新，围绕平台的出行场景，继续发展平台独特的竞争优势和价值，以更好地服务用户群体。未来，嘀嗒出行计划进一步发展聚合打车业务及其他出行相关服务，并持续扩展服务品类。有关嘀嗒出行截至2025年12月31日止年度全年业绩公告的完整内容，请访问：https://manager.wisdomir.com/files/594/2026/0320/20260320220001_60101381_en.pdf关于嘀嗒出行嘀嗒出行（"嘀嗒"或"公司"，股票代码：02559.HK）是中国领先的技术驱动型出行平台。公司通过提供顺风车平台服务，为乘客和出行路线及时间相近的私家车主进行匹配，从而在不增加环境负担的前提下创造了更多运力。公司还提供聚合打车服务，以满足更多元的出行场景需求。嘀嗒出行致力于让出行生态更绿色、更高效，让每一次出行体验温暖而愉悦。前瞻性声明本新闻稿包含有关公司业务前景、预测业务计划和增长战略的前瞻性陈述。这些前瞻性陈述基于公司目前信息，并基于本新闻稿发布时的前景进行陈述。它们基于某些期望、假设和前提，其中一些是主观的或不可控的，可能被证明是不正确的，未来可能无法实现。前瞻性陈述背后存在大量风险和不确定性。有关这些风险和不确定性的更多信息，请参阅公司网站上的其他公开披露文件。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, March 24, 2026 - (ACN Newswire via SeaPRwire.com) – Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK), a leading technology-driven mobility platform, announced the audited consolidated annual results for the year ended December 31, 2025.Financial Highlights:- Revenue was RMB502.4 million for the year ended December 31, 2025, compared to RMB787.2 million for the year ended December 31, 2024.- Gross profit was RMB332.9 million for the year ended December 31, 2025, compared to RMB567.0 million for year ended December 31, 2024.- Net profit was RMB129.8 million for the year ended December 31, 2025, compared to RMB1,004.3 million for the year ended December 31, 2024.- Adjusted net profit (non-IFRS measure) was RMB137.9 million for the year ended December 31, 2025, compared to RMB221.4 million for the year ended December 31, 2025.Operation Highlights:- Gross transaction value amounted to RMB4.7 billion and the total number of orders reached 80.9 million for the year ended December 31, 2025.- Registered users reached over 415 million as of December 31, 2025.- The number of certified private car owners reached approximately 21 million as of December 31, 2025.Business OutlookMobility-related business 2025 marked a pivotal year as the Company transitioned from a single-focus carpooling platform toward a more integrated mobility and vehicle services platform. In 2025, the Company launched ride-hailing aggregation platform services to diversify service offerings. Such services are intended to complement the carpooling business by addressing additional mobility scenarios, including short-to-medium distance and immediate travel needs, in addition to the medium-to-long distance and pre-arranged travel scenarios typically served by carpooling. The Company also commenced used car trading referral services to expand business scope along the vehicle ownership lifecycle and enhance engagement within the Company’s car owner ecosystem. The Company believes carpooling in China is still at its early stage of development, with significant market demand yet to be fully released and the benefits of carpooling not fully recognized by the public. The Company will remain committed to innovation as the Company continues to develop unique competitive strengths and value around mobility scenarios to better serve the user base. In the future, the Company plans to further develop ride-hailing aggregation platform services and other mobility-related services and to continue to expand service offerings.For the full announcement of Dida for the annual results ended December 31, 2025, please visit:https://manager.wisdomir.com/files/594/2026/0320/20260320220001_60101381_en.pdf About Dida Inc.Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK) is a leading technology-driven mobility platform in China. The Company creates more transit capacity with less environmental impact by providing carpooling marketplace services to pair up riders with private car owners if they are heading in similar directions at compatible times. It also provides ride-hailing aggregation platform services to address additional mobility scenarios. Dida makes the mobility ecosystem greener and more efficient, and each trip experience warm and enjoyable.Forward-Looking StatementsThis press release contains forward-looking statements relating to the business outlook, forecast business plans and growth strategies of the Company. These forward-looking statements are based on information currently available to the Company and are stated herein on the basis of the outlook at the time of this press release. They are based on certain expectations, assumptions and premises, some of which are subjective or beyond the control. These forward-looking statements may prove to be incorrect and may not be realized in future. Underlying the forward-looking statements is a large number of risks and uncertainties. Further information regarding these risks and uncertainties is included in the other public disclosure documents on the corporate website. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 24, 2026 - (ACN Newswire via SeaPRwire.com) - On March 23, 2026, Tingyi (Cayman Islands) Holding Corp. (0322.HK, the “Company”, together with its subsidiaries, the “Group”) is pleased to announce its 2025 annual results. In 2025, amid drastic changes in consumer behaviours and a complex market environment, the Group remained firmly committed to the consumer-centric approach, advanced the high-quality development in a coordinated manner, promoted product innovation and upgrades to precisely meet the demands of diverse scenario-based needs, while accelerating the expansion into high-growth channels. It comprehensively improved overall operational efficiency and drove steady growth of all key financial indicators. For the twelve months ended on December 31, the Group’s revenue decreased by 2.0% year-on-year to RMB 79.068 billion. Among which, the revenue from the Instant Noodles Business was RMB28.421 billion, while the revenue from the Beverages Business was RMB50.123 billion. The gross profit margin grew 1.7 percentage points to 34.8% year-on-year, EBITDA increased by 10.2% year-on-year to RMB 10.607 billion. The profit attributable to shareholders of the Company increased significantly by 20.5% year-on-year to RMB4.501 billion. The directors recommended the payment of a final dividend and a special final dividend of RMB39.92 cents and RMB39.92 cents per ordinary share respectively. Dividend payout ratio for the year remained at 100%.Financial Summary For the twelve months ended 31 December RMB’00020252024ChangeRevenue79,068,02280,650,914↓ 2.0%Gross margin34.8%33.1%↑ 1.7ppt.Gross profit of the Group27,531,70426,695,643↑ 3.1%EBITDA10,606,5229,627,802↑ 10.2%Profit for the period5,175,8524,322,135↑ 19.8%Profit attributable to owners of the Company4,500,6983,734,429↑ 20.5%Earnings per share (RMB cents) Basic79.8666.28↑ 13.58 centsDiluted79.8466.28↑ 13.56 centsAs at 31 December 2025, cash at bank and on hand (including long-term time deposits) was RMB19,486.056 million, representing an increase of RMB3,483.388 million when compared to 31 December 2024. Gearing ratio was -29.8%.In 2025, China's economy demonstrated resilience with a 5% year-on-year GDP growth. However, the food and beverage market entered into the stage of stock competition and demand upgrading for functional and emotional values. Brand, quality, and flavors remained key drivers of purchasing decisions. Additionally, emerging formats such as instant retail, snack discount stores, and membership stores had brought about drastic changes in channels and consumer behaviors. Against the backdrop of intensifying market competition and evolving consumption patterns, a company's core competitiveness increasingly lies in building a strong moat for their core brands. Those that continuously drive product innovation and channel optimization around consumer needs will be more agile in capturing market opportunities, strengthening consumer trust, and ultimately achieving high-quality and sustainable long-term development.In 2025, the gross profit of the Instant Noodles business improved steadily. The Group’s revenue from the Instant Noodles Business was RMB28.421 billion, which grew slightly year-on-year, accounting for 35.9% of the Group’s total revenue. During the year, due to favorable raw material prices and selling prices, the gross profit margin of instant noodles expanded by 1.1 percentage points year-on-year to 29.7%, and the profit attributable to shareholders of the Company for the year of 2025 in the Instant Noodles Business increased significantly by 10.1% year-on-year to RMB 2.252 billion, driven by the year-on-year increase in gross profit margin. During the year, in the face of intensifying industry competition, the Instant Noodles Business steadily advanced its core strategy of “consolidating blockbuster products, seizing the popular flavors track, and cultivating innovative products.” By continuously improving the product portfolio and forging deep collaborations with popular IPs, it effectively amplified brand presence and steadily optimized gross margin structure. On the product front, the business relied on deep cultivation of core blockbuster products and iterative flavor upgrades, while closely aligning with evolving consumer trends to precisely target the health-focused and premium market segments, tapping into new growth opportunities. On the marketing front, it leveraged mainstream social platforms such as Bilibili and Xiaohongshu to conduct omnichannel communication, combined with cross-industry collaborations with well-known IPs to reinforce the brand perception of high-end and convenient consumption. As a result, brand influence and market recognition improved significantly. Meanwhile, guided by aerospace-grade quality standards, the business promoted the full application of aerospace patented temperature control technology in the production line, fully demonstrating the brand’s differentiated advantages in product quality and technological innovation.The Beverages Business firmly executed the strategy of “consolidating core products and developing innovative products”, the revenue from the Beverages Business was RMB50.123 billion, accounting for 63.4% of the Group’s total revenue. During the year, due to favorable raw material prices and optimized product mix, the gross profit margin of Beverages expanded by 2.2 percentage points year on-year to 37.5%. Driven by a year-on-year expansion of gross profit margin, the profit attributable to shareholders of the Company in the Beverages Business for the year of 2025 increased significantly by 18.5% year-on-year to RMB 2.274 billion. During the year, the Beverages Business strengthened its core category advantages and proactively positioned itself in emerging tracks, establishing a collaborative growth model across the full product portfolio. On the product front, while consolidating core products, it continuously expanded into incremental growth segments by launching high-quality sugar-free offerings and aligning with the wellness consumption trend to create herbal wellness scenarios, successfully opening up new growth spaces such as products made from homologous medicinal and food materials. On the marketing front, the Company deepened IP collaborations to broaden audience reach, enhanced its presence in cultural tourism channels and high-end hotel partnerships, and targeted premium consumption scenarios. These efforts consistently elevated brand value, providing strong support for the business to achieve steady operations and sustainable growth.Mr. Wei Hong-Chen, Chief Executive Officer, commented, “As the first year of the 15th Five-Year Plan period, 2026 is expected to see expanding domestic demand become a key driver of economic growth under a more proactive and effective macroeconomic policy, while the consumer market will also usher in a critical window of profound transformation. The food and beverage industry will closely follow the theme of high-quality development, and consumption stratification will become more refined. Functional attributes, emotional resonance, and green concepts are shifting from trends to mainstream factors, becoming core elements driving brand growth. In the face of opportunities and challenges in the new cycle, the Group will be guided by the spirit of “Back to Day 1” as its strategic direction, embracing the efficiency, agility and entrepreneurial drive of our founding days, and building a platform that encourages honesty, bold experimentation and mutual growth, thus fully unleashing the vitality of all employees. While unleashing organizational vitality, we will continue to strengthen our foundational R&D capabilities and digital operation systems. Rooted in the health needs of the nation, we will drive product iteration and upgrades through technological innovation, continuously elevate product value, and align high-quality supply with the evolving consumption landscape. Adhering to the “economic-ESG” sustainable development philosophy, we will internalize social responsibility as the foundation of our development, solidify user trust through quality products, build a brand moat with long-term value, and create a sustainable and stable return system for shareholders, propelling the Group toward steady and sustained progress in the new stage of high-quality development.”About Tingyi (Cayman Islands) Holding Corp. (0322.HK)Tingyi (Cayman Islands) Holding Corp. (the “Company”), and its subsidiaries (the “Group”) specialise in the production and distribution of instant noodles and beverages in the People’s Republic of China (the “PRC”). The Group started its instant noodle business in 1992, and expanded into instant food business and beverage business in 1996. In March 2012, the Group further expanded its beverage business by forming a strategic alliance with PepsiCo for the beverage business in the PRC. The Company exclusively manufactures, bottles, packages, distributes and sells PepsiCo soft drinks in the PRC. After years of hard work and accumulation, “Master Kong” has become one of the best-known brands among consumers in the PRC.For enquiries, please contact:Investor EnquiriesInvestor Relations Team, Tingyi (Cayman Islands) Holding Corp.E-mail: ir@tingyi.comChristensen China LimitedStephanie ChenE-mail: stephanie.chen@christensencomms.comTel: +852 2117 0861 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 2026年3月23日，康师傅控股有限公司（0322.HK，以下简称"公司"，连同其附属公司"集团"）发布2025年年度业绩公告。2025年，在消费行为剧烈变革与市场环境复杂多变的背景下，本集团始终坚持以消费者为中心，统筹推进高质量发展，推动产品创新升级，精准满足多元场景需求，同时加速开拓高增长渠道，全面提升整体运营效能，推动各项财务指标稳健发展。截至2025年12月31日止十二个月，集团收益同比衰退2.0%至790.68亿人民币。其中，方便面事业收益284.21亿人民币，饮品事业收益为501.23亿人民币。毛利率同比提高1.7个百分点至34.8%，EBITDA同比增长10.2%至106.07亿人民币，本公司股东应占溢利同比成长20.5%至45.01亿人民币。董事会建议派发末期股息每股普通股人民币39.92分及特别末期股息每股普通股人民币39.92分，全年派息率达100%。财务摘要 截至12月31日止12个月 人民币千元2025年2024年变动收益79,068,02280,650,914↓ 2.0%毛利率（%）34.8%33.1%↑ 1.7个百分点集团毛利27,531,70426,695,643↑ 3.1%扣除利息、税项、折旧及摊销前盈利（EBITDA）10,606,5229,627,802↑ 10.2%本期溢利5,175,8524,322,135↑ 19.8%本公司股东应占溢利4,500,6983,734,429↑ 20.5%每股溢利（人民币分） 基本79.8666.28↑ 13.58分摊薄79.8466.28↑ 13.56分于2025年12月31日之银行存款及现金（含长期定期存款）为人民币19,486,056千元，相较2024年12月31日增加人民币3,483,388千元，净负债与资本比率为-29.8%。2025年，中国经济在GDP同比5%的增长中展现韧性。但食品饮料市场进入存量博弈，以及对功能价值与情绪价值需求升级阶段。品牌、品质与风味仍是购买决策的重要驱动因素。此外，即时零售、零食折扣店、会员店等新兴业态带来渠道与消费行为剧烈变革。在市场竞争日趋激烈、消费行为持续演变的背景下，企业的核心竞争力愈发体现在核心品牌的护城河建设。能够围绕消费者需求，持续推动产品创新与渠道优化的企业，将更敏捷地捕捉市场机遇，巩固消费者信任，进而实现高质量、可持续的长远发展。2025年，方便面事业的毛利结构持续改善。方便面事业收益为284.21亿人民币，同比微幅增长，占集团总收益35.9%。年内，因原材料价格及售价有利，使方便面毛利率同比提高1.1个百分点至29.7%，由于毛利率同比提高带动，令方便面事业2025年全年的本公司股东应占溢利同比大幅增长10.1%至22.52亿人民币。年内，面对日趋激烈的行业竞争，方便面业务扎实推进"巩固大单品、占领大口味赛道、培育创新产品"的核心战略，通过持续完善产品矩阵，与热门IP深度联动，有效放大品牌声量，稳步优化毛利结构。产品端，依托核心大单品深耕与口味迭代升级，同时紧密贴合消费趋势变化，精准布局健康化、高端化赛道，精准切入新增量市场。营销端，依托B站、小红书等主流社交平台开展全域传播，叠加知名IP跨界合作，深化高端便捷的品牌认知，品牌影响力与市场认知度显著提升。同时，以航天品质为引领，推动航天专利温控技术在生产线全面落地应用，充分彰显品牌在产品品质与科技含量的差异化优势。饮品事业坚定实施"巩固核心单品、发展创新产品"战略。饮品事业整体收益为501.23亿人民币，占集团总收益63.4%。年内，因原材料价格有利及产品组合优化，使饮品毛利率同比提高2.2个百分点至37.5%。由于毛利率同比提高带动，令饮品事业2025年全年本公司股东应占溢利同比大幅提高18.5%至22.74亿人民币。年内，饮品事业通过深化核心品类优势与前瞻性布局新兴赛道，构建全品类协同增长格局。产品端，在稳固核心单品的基础上，持续拓展增量赛道，推出高品质无糖产品，并紧扣养生消费趋势，打造草本养生场景，成功开辟药食同源等新增量空间。营销端则持续强化IP深度合作拓宽受众圈层，同时强化文旅渠道布局及高端酒店合作，锚定高端消费场景，持续提升品牌价值，为业务实现稳健经营与可持续增长提供有力支撑。康师傅首席执行官魏宏丞先生表示："2026年作为"十五五"开局之年，预计在更加积极有为的宏观政策下，扩大内需将成为经济增长的关键着力点，消费市场也将随之迎来深度变革的关键窗口。食品饮料行业围绕高质量发展主线持续演进，消费分层愈加精细，功能价值、情绪共鸣与绿色理念正从趋势走向主流，成为驱动品牌增长的核心要素。面对新周期中的机遇与挑战，集团将以"Back to Day 1"的精神为战略引领，回归创业初期的高效敏捷与狼性拼搏文化，打造敢讲真话、勇于尝试、共同成长的平台，充分激发全员活力。在释放组织活力的同时，我们将持续夯实基础研发能力与数字化运营体系，立足国民健康诉求，以科技创新驱动产品迭代升级，推动产品价值不断跃迁，以高品质供给适配新消费结构。秉持"economic-ESG"可持续发展理念，我们将社会责任内化为发展底色，通过优质产品夯实用户信赖，以长期价值构建品牌护城河，为股东打造可持续的稳健回报体系，推动集团在高质量发展新阶段行稳致远。"关于康师傅控股有限公司(0322.HK)康师傅控股有限公司（"本公司"）及其附属公司（"本集团"）主要在中国从事生产和销售方便面及饮品。本集团于1992年开始生产方便面，并自1996年起扩大事业至方便食品及饮品；2012年3月，本集团进一步拓展饮料事业范围，完成与PepsiCo中国饮料事业之战略联盟，开始独家负责制造、灌装、包装、销售及分销PepsiCo于中国的非酒精饮料。"康师傅"作为中国家喻户晓的品牌，经过多年的耕耘与积累，深受中国消费者喜爱和支持。如有垂询，请联络：投资者查询康师傅控股有限公司投资者关系团队电邮：ir@tingyi.com汇思讯中国有限公司陈敏芝电邮：stephanie.chen@christensencomms.com电话：+852 2117 0861 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月24日 - (亚太商讯 via SeaPRwire.com) - 3月23日，麦迪卫康正式发布2025年度业绩公告。 数据显示，公司年内溢利约人民币698万元，盈利能力显著修复，全年扭亏为盈，经营性现金流状况持续好转。 业绩改善主要得益于“AI+数字化”带动核心主营业务持续稳健增长，叠加公司聚焦高毛利优质项目，有效带动整体毛利水平显著提升。此次公司财务表现展现出强劲的修复弹性，是公司发展历程中的重要里程碑。 一方面，标志着公司聚焦主业、优化业务结构的战略取得实质性成效，经营质量与盈利能力迈入全新阶段，为后续稳健发展筑牢财务根基; 另一方面，充分印证公司核心业务具备强劲增长韧性与市场竞争力，高毛利项目布局持续释放效益，也为公司深化医疗健康服务布局、拓展优质业务版图注入更强信心，进一步巩固行业竞争力与可持续发展能力。3C服务体系覆盖全产业链 技术创新构筑核心竞争力经营效率的跨越式进步，离不开公司清晰的业务布局与精准的战略定位。 在业务布局方面，麦迪卫康以创新数字医疗服务提供商为定位，打造独具竞争力的「3C服务体系」，涵盖专业医学内容服务（Content）、高端学术会议服务（Conference）、企业市场推广服务（Corporation）三大核心领域，形成了覆盖医疗全产业链的服务闭环，为业务高质量发展筑牢根基。2025年，公司数字化医学平台的运营步入高质量发展的新阶段。 该平台不仅实现了专业医疗群体的高密度覆盖，更在海量的学术交流与卫教传播中，构筑起一套精准、专业且具备高度粘性的知识服务体系。 这种深度的数字化转型，不仅显著提升了医学内容的传播效能与学术影响力，更在赋能医生临床决策、助力健康知识普及方面发挥了关键作用，转化为推动行业进步的实质性力量，进一步巩固了公司在数字医疗生态中的引领地位。持续的技术创新，是驱动麦迪卫康高质量增长的核心引擎。 在技术研发领域，公司拥有多项软件著作权与发明专利，自主研发的长颈鹿系列数智平台已吸引数十万名医生入驻，显著提升医疗服务与运营管理效率。 2024年，公司持续深化AIGC场景落地，创新推出「AI智能体+医生众创」模式，助力医生回归高价值诊疗与科研工作; 同时依托区块链技术成功获得数据服务商资质，实现医学内容确权与授权运营，为医疗数字化生态建设树立行业标杆。2025年，公司深入推进AI智能体的研发与场景应用探索，致力于与医疗专业人士协同，打造「AI+人工」深度融合的医学内容数据标注及版权内容生产体系，并与数字资产交易平台业务形成有机衔接。 此外，依托专病管理AI智能体所取得的阶段性突破，公司正进一步将数智化能力向产业上下游延伸，前瞻性地探索智能专病机器人赛道； 同时，通过对柏慧康生物的战略投资，公司正积极探索在多组学创新检测领域的落地应用并已取得阶段性进展，借此构建起立体化的医疗创新服务网络。全国服务网络纵深覆盖 打开长期价值成长空间依托成熟的业务体系与核心技术支撑，麦迪卫康已搭建起覆盖全国的专业服务网络。 目前，公司在全国设立近10家经营机构，重点布局北京、上海、南京等核心医疗枢纽城市，服务合作三级医疗机构超3000家，其中包括北京天坛医院、阜外医院等国内顶尖三甲医院。同时，公司深度参与卒中中心、胸痛中心等重点专科建设，构建起纵向贯通、横向协同的全域专科医疗服务体系，为业务高效落地与市场持续拓展提供了坚实保障。广泛覆盖的服务网络与专业高效的服务能力，让麦迪卫康积累起优质且多元的客户群体，行业龙头地位持续巩固。 在数字医疗领域，公司自有互联网医疗平台已汇聚注册医生超5万名、注册患者近36万人次，2025年线上咨询量突破50万次，同比增长超19%，实现优质医疗资源高效触达，有效缓解医疗资源分配不均难题。从行业发展趋势来看，在人口老龄化加剧、慢性病管理需求攀升、政策持续赋能及AI数字技术深度渗透等多重驱动下，中国数字医疗产业正迎来黄金发展期，据中商产业研究院数据预测，2025年中国数字医疗市场规模预计达5800亿元， 2031年突破1.2万亿元，广阔的市场增量为麦迪卫康这类具备核心技术壁垒与全链条布局的领军企业，提供了持续成长与价值释放空间。麦迪卫康以「3C服务体系」为基座，以技术创新与服务升级为引擎，凭借覆盖全国的服务网络、广泛优质的客户资源以及前瞻性的战略布局，在行业内构建了独特的竞争优势与地位。 未来，随着数字医疗产业的持续升温与公司业务的不断深化，公司将紧抓医疗智能化转型的时代机遇，聚焦AI小模型赋能，全面拓展业务版图，夯实「AI+区块链」技术底座，探索搭建全流程智能闭环体系。 同时以「医学专业服务+数字化技术」双轮驱动，持续拓宽业务边界、优化内部运营效能，在数字医疗赛道上实现更高质量的发展，打开广阔成长空间。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Sydney, Australia--(ACN Newswire via SeaPRwire.com - March 23, 2026) - The International Career Institute (ICI) is marking its 20th anniversary with the launch of 100 scholarships, in a milestone initiative designed to widen access to flexible, career-focused online study. The scholarship announcement comes as more students look for practical ways to upskill, change careers or strengthen their professional credentials without putting work or family life on hold.New scholarships launched as International Career Institute celebrates two decades of career-focused educationTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10373/288837_60f2135b4402f876_001full.jpgOver the past two decades, the International Career Institute has built its reputation as an independent private provider of online education focused on practical, job-relevant learning. ICI offers 57 courses, has supported 58,453 students, and has learners in 191 countries, reflecting a substantial international footprint.The anniversary scholarship campaign is intended to do more than mark a birthday. It reflects a wider shift in the education market, where students are increasingly prioritising flexibility, affordability and direct career outcomes. ICI positions itself around exactly those needs: online delivery, self-paced study, personal tutor support, included course materials, flexible payment plans and career services aimed at helping graduates move into employment or advance in their chosen field.Applicants for the Leadership Scholarships are asked to demonstrate leadership potential or current leadership responsibilities and to complete an application process that outlines their background and motivation for study. Applicants facing financial disadvantage will be given priority. The scholarship forms part of a broader ICI scholarship offering and positions the initiative as a way to recognise leadership and help recipients take the next step in their development.For many adult learners, flexibility is not simply an added benefit; it is the condition that makes study possible. At the International Career Institute, students can study at their own pace, with no classes to attend and no additional textbooks or materials to purchase. Its online study model is structured around module-based written assessments rather than traditional exams, while students receive guidance and feedback from personal tutors throughout the course.Dr Michael Machica, Director of the International Career Institute, said the anniversary was both a celebration of the institution's history and a statement of intent for its future."Reaching 20 years is a proud milestone for the International Career Institute and a moment to reflect on how education has changed. From the beginning, our goal has been to make career-focused learning more flexible, more practical and more accessible for people whose lives do not fit the traditional study model. Over the next 20 years, we see ICI continuing to expand its reach, strengthen its industry relevance and help even more learners build meaningful careers through online education that works in the real world."That long-term focus on accessibility and employability remains central to the International Career Institute brand. Central to ICI's offering is tutor support, affordable pricing, interest-free payment plans, included materials and graduate career services. Those services include assistance with resumes, job searches, cover letters and interview preparation - features that help distinguish ICI in a competitive online learning market where students are increasingly outcome-focused.ICI's programmes are developed in consultation with industry experts and aligned with real-world job opportunities. That proposition - flexible study paired with career relevance - has become increasingly important as more learners seek education that fits around existing work, business, or family commitments while still contributing to employability and advancement.The release of 100 scholarships also gives the anniversary a broader public-interest dimension. In a cost-conscious environment, even motivated learners can hesitate when considering professional study. By offering scholarships focused on leadership and development, ICI is positioning its 20th anniversary not simply as a milestone but as an opportunity to invest in the next generation of professionals and career changers.Prospective students can explore scholarship eligibility, course options and the International Career Institute online study model through the institute's website, where they can also view course pages, student reviews and information about graduate support. For those considering a career change, promotion pathway or a more flexible way to formalise their skills, the anniversary scholarships create a timely reason to act.About International Career InstituteICI is an independent private provider of online education and training established in 2006. It offers career- and lifestyle-focused courses through a fully online, self-paced study model supported by personal tutors and graduate career services.Media ContactFor media enquiries, please contact:Email: info@ici.net.au Website: www.ici.net.auInternational Career InstituteTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10373/288837_60f2135b4402f876_002full.jpgTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/288837 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com